Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3025577	b-cr	ug/l (ug/l)	1741	3215	0.03%
3025577	b-cr	— (—)	1027	1458	100.00%	Distribution not available
3025577	b-cr	ug/l______ (ug/l)	45	62	0.00%
3025577	b-cr	UG/L (ug/l)	12	18	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Coxarthrosis, primary, with hip surgery

2012

267.79

307.65

2.2

1.9

2.35

2.27

ug/l

0.06

1682

Finngen Rheumatological endpoints

745

178.16

307.65

2.2

1.3

2.34

2.22

ug/l

0.04

614

Coxarthrosis, primary

2026

199.19

307.65

2.2

1.9

2.34

2.31

ug/l

0.02

1696

Artrosis, including avohilmo

569

92.56

307.65

2.2

1.4

2.43

1.49

ug/l

2.55

472

Complications of internal orthopaedic prosthetic devices, implants and grafts

800

468

18.36

307.65

2.3

2.2

3.11

2.02

ug/l

3.74

697

376

Primary coxarthrosis, bilateral

1418

478.39

307.65

2.3

1.5

2.41

1.87

ug/l

0.31

1185

Complications of surgical and medical care, not elsewhere classified

966

1155

5.65

307.65

2.3

2.2

2.85

1.84

ug/l

8.55

836

938

Complications of medical and surgical care

699

1399

4.54

276.67

2.4

2.1

2.93

2.04

ug/l

5.38

590

1168

Glucosamine medication

602

1009

4.86

246.10

2.4

2.1

2.49

2.44

ug/l

0.08

514

833

Oter anti-inflammatory and antirheumatic agents, non-steroids

255

31.73

243.49

2.2

1.7

2.00

1.58

ug/l

0.80

207

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

587

1305

4.47

233.87

2.4

2.1

2.77

2.02

ug/l

3.86

503

1083

therapeutic use

155

28.98

226.49

2.4

2.3

3.67

1.72

ug/l

4.01

123

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

573

1333

4.35

221.50

2.4

2.1

2.78

2.15

ug/l

2.77

490

1105

Tramadol

573

703

4.94

214.46

2.3

2.2

2.34

2.44

ug/l

0.17

491

594

Sequelae with surgical and medical care as external cause

320

484

6.80

201.52

2.2

2.85

2.41

ug/l

0.74

281

399

Sequelae of external causes of morbidity and mortality

347

605

5.87

189.34

2.2

2.83

2.32

ug/l

1.11

301

498

Oxicams

197

25.19

183.00

2.2

1.7

2.40

1.58

ug/l

1.71

167

Gonarthrosis,primary

713

1253

3.46

171.85

2.3

2.2

2.39

2.26

ug/l

0.28

596

1044

Orthopaedic devices associated with adverse incidents

112

31.07

165.84

2.2

3.73

2.24

ug/l

1.55

Presence of other functional implants

546

1107

3.41

134.62

2.1

2.2

1.97

2.38

ug/l

2.18

466

917

Codeine

497

703

3.84

133.00

2.3

2.2

2.38

2.44

ug/l

0.08

407

594

Coxibs

155

18.21

122.76

2.3

1.7

2.02

1.58

ug/l

0.69

128

Gonarthrosis, primary, with knee surgery

486

1154

3.31

119.21

2.2

2.72

2.32

ug/l

1.08

412

960

Primary gonarthrosis, bilateral

434

1075

3.42

114.11

2.3

2.2

2.60

2.30

ug/l

0.65

373

889

Artificial joint operation, meniscal resection

625

1447

2.78

108.11

2.3

2.2

2.47

2.23

ug/l

0.67

531

1203

Codeine or tramadol medication

637

1242

2.80

106.08

2.3

2.1

2.28

2.38

ug/l

0.23

528

1039

Opioids

458

703

3.38

101.32

2.2

2.45

2.44

ug/l

0.02

380

594

Acetic acid derivatives and related substances

134

15.49

99.05

2.1

1.7

2.35

1.58

ug/l

1.06

110

Spinal stenosis

419

980

3.18

95.08

2.3

2.2

2.41

2.36

ug/l

0.08

355

815

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

527

1237

2.70

86.62

2.2

2.49

2.32

ug/l

0.32

443

1031

Spondylopathies

485

1039

2.78

81.93

2.3

2.2

2.22

2.32

ug/l

0.23

415

864

Propionic acid derivatives

10.78

59.28

2.1

1.7

2.00

1.58

ug/l

0.64

Injuries to the hip and thigh

343

1195

2.59

56.93

2.3

2.1

3.02

2.20

ug/l

1.77

298

978

Spondylosis

337

1014

2.61

55.14

2.3

2.2

2.27

2.32

ug/l

0.10

289

846

Anti-inflammatory and antirheumatic products, non-steroids

10.21

54.64

2.2

1.7

1.94

1.58

ug/l

0.52

Complications of procedures, not elsewhere classified

355

1146

2.50

53.84

2.2

2.47

1.84

ug/l

2.88

296

932

Exposure to unspecified factor

513

1631

2.15

52.58

2.3

2.2

2.62

2.24

ug/l

0.97

431

1360

Parasetamol

256

412

3.15

51.05

2.1

2.2

2.13

2.57

ug/l

0.62

211

338

Dislocation, sprain and strain of joint and ligaments of hip

9.14

48.65

2.1

2.3

2.84

2.28

ug/l

0.43

Osteonecrosis

147

6.02

48.30

2.4

2.1

2.33

2.21

ug/l

0.11

127

Other intervertebral disc disorders

399

1041

2.29

46.41

2.3

2.2

2.30

2.34

ug/l

0.07

338

864

Nerve, nerve root and plexus disorders

518

1574

1.98

41.97

2.4

2.2

2.39

2.27

ug/l

0.30

425

1318

Postprocedural musculoskeletal disorders, not elsewhere classified

174

5.12

41.22

2.4

2.3

2.23

2.25

ug/l

0.02

150

Pain in limb

375

1088

2.20

40.25

2.2

2.28

2.36

ug/l

0.14

308

903

Other disorders of the musculoskeletal system and connective tissue

129

364

3.59

38.79

2.4

2.2

2.14

2.32

ug/l

0.23

111

305

Shoulder lesions

379

1082

2.11

36.17

2.3

2.2

2.27

2.35

ug/l

0.17

328

901

Carpal tunnel syndrome

319

1320

2.10

32.95

2.5

2.2

2.79

2.33

ug/l

1.38

276

1109

Paracetamol or NSAID medication

15.91

32.38

2.3

2.1

1.95

1.94

ug/l

—

Rotator cuff syndrome

325

1068

2.10

32.05

2.3

2.2

2.47

2.35

ug/l

0.23

280

890

Dorsopathies

405

1043

1.97

31.13

2.3

2.2

2.22

2.34

ug/l

0.22

344

865

Other soft tissue disorders, not elsewhere classified

380

1091

1.99

30.77

2.3

2.2

2.35

2.36

ug/l

0.00

317

905

Lumbar disc prolapse

288

1021

2.10

28.71

2.3

2.2

2.23

2.33

ug/l

0.16

244

848

External causes of morbidity and mortality

231

499

2.33

26.71

2.2

2.1

2.58

1.78

ug/l

1.52

197

404

Osteopathies and chondropathies

294

1354

1.99

26.65

2.3

2.2

2.66

2.40

ug/l

0.37

251

1119

Low back pain

305

1038

1.99

25.94

2.2

2.42

2.33

ug/l

0.13

254

862

Care involving use of rehabilitation procedures

308

1443

1.93

25.28

2.4

2.2

2.30

ug/l

0.00

261

1222

Other bacterial diseases, including avohilmo

425

1531

1.74

23.38

2.2

2.42

2.31

ug/l

0.17

353

1280

Rheumatoid arthritis, including avohilmo

206

964

2.15

23.30

2.2

2.91

2.34

ug/l

0.68

169

806

Superficial injury of hip and thigh

102

346

2.97

22.86

2.3

2.2

2.95

2.02

ug/l

0.81

291

Other dorsopathies, not elsewhere classified

366

1043

1.83

22.82

2.2

2.14

2.34

ug/l

0.43

302

865

Fracture of femur

175

691

2.30

22.82

2.2

2.1

2.96

2.30

ug/l

1.05

153

572

Oxycodone

170

631

2.31

22.35

2.0

2.1

2.43

2.45

ug/l

0.02

124

534

Dorsalgia

357

1043

1.82

22.05

2.1

2.2

2.22

2.34

ug/l

0.22

291

865

Pain in joint

265

824

1.98

21.94

2.3

2.2

2.24

2.18

ug/l

0.10

214

695

Congenital malformations and deformations of the musculoskeletal system

5.13

21.72

2.3

2.1

3.60

2.64

ug/l

0.26

Seropositive rheumatoid arthritis, wide

155

666

2.34

21.62

2.1

2.2

2.95

2.41

ug/l

0.45

127

564

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

153

656

2.35

21.46

2.2

2.95

2.42

ug/l

0.45

126

558

Other/unspecified seropositive rheumatoid arthritis

154

663

2.34

21.39

2.2

2.95

2.41

ug/l

0.45

127

563

Persons encountering health services for specific procedures and health care

419

1468

1.69

20.65

2.2

2.38

2.29

ug/l

0.21

343

1241

Erysipelas, including avohilmo

353

1503

1.74

20.52

2.3

2.2

2.71

2.30

ug/l

0.81

298

1253

Lower back pain or/and sciatica

446

1688

1.65

20.21

2.2

2.46

2.29

ug/l

0.37

376

1407

Deforming dorsopathies

127

517

2.47

19.96

2.5

2.2

2.18

2.51

ug/l

0.54

109

424

Dental operations

261

702

1.92

18.92

2.1

2.2

2.05

2.29

ug/l

0.45

225

598

Methotrexate

298

2.91

18.66

2.2

2.77

2.66

ug/l

0.08

257

Fall on same level

435

1422

1.63

18.60

2.2

2.36

2.29

ug/l

0.14

352

1195

Soft tissue disorders

363

1092

1.71

18.09

2.2

2.26

2.36

ug/l

0.13

305

905

Other bacterial diseases

399

1625

1.63

17.71

2.2

2.44

2.29

ug/l

0.24

330

1362

Injury, poisoning and certain other consequences of external causes

168

390

2.16

16.72

2.2

2.1

2.72

1.72

ug/l

1.39

143

315

Sciatica+with lumbago

206

958

1.91

16.69

2.2

2.36

2.30

ug/l

0.07

178

792

Other external causes of accidental injury

291

825

1.77

16.47

2.2

2.1

2.63

2.07

ug/l

0.78

239

686

Exposure to other specified factors

318

1639

1.67

16.29

2.3

2.2

2.65

2.26

ug/l

0.84

257

1376

Oral corticosteroids

418

1553

1.58

16.07

2.2

2.24

2.35

ug/l

0.19

347

1297

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

130

3.69

15.38

2.3

2.2

3.56

2.31

ug/l

0.40

114

Accidents

286

825

1.74

15.32

2.3

2.1

2.63

2.07

ug/l

0.77

236

686

Dyspnoea

376

1719

1.58

15.12

2.2

2.20

2.35

ug/l

0.46

307

1445

Inflammatory bowel disease treatment related agents

433

1555

1.55

15.03

2.2

2.27

2.35

ug/l

0.14

361

1298

ILD medications: prednisolone, methylprednisolone, prednisone

413

1474

1.56

14.89

2.3

2.2

2.33

2.37

ug/l

0.06

342

1239

Sulfasalazine

130

611

2.14

14.76

2.3

2.2

2.11

2.50

ug/l

0.81

105

509

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

400

1625

1.56

14.75

2.2

2.45

2.19

ug/l

0.49

325

1364

Disorders of synovium and tendon

209

979

1.82

14.44

2.3

2.2

2.16

2.39

ug/l

0.53

175

815

Enthesopathies of lower limb, excluding foot

396

2.41

14.35

2.5

2.2

2.10

2.65

ug/l

0.87

324

ILD medications

419

1475

1.53

13.95

2.2

2.31

2.37

ug/l

0.09

343

1239

ILD medications: immunosuppressive drugs

254

1366

1.69

13.80

2.3

2.2

2.33

2.39

ug/l

0.09

210

1149

Other disorders of bone

350

2.47

13.72

2.5

2.2

2.33

2.30

ug/l

0.03

291

Reimbursement for rheumatic diseases

240

1403

1.70

13.72

2.2

2.28

2.47

ug/l

0.37

193

1165

Non-invasive ventilation

109

420

2.25

13.68

2.9

2.2

2.07

2.65

ug/l

0.99

362

Other heart diseases

140

438

2.08

13.68

2.4

2.3

2.99

2.62

ug/l

0.24

121

381

Disease of hard tissues of teeth, NOS

247

742

1.75

13.62

2.1

2.2

2.26

2.18

ug/l

0.14

205

625

Artificial joint re-operation

178

3.13

13.60

2.3

2.2

2.84

2.13

ug/l

0.86

153

Other (seronegative) rheumatoid arthritis, wide

104

469

2.23

13.17

2.2

2.3

2.69

2.54

ug/l

0.13

402

Spondylolisthesis/Spondylolysis

364

2.40

13.10

2.7

2.2

2.33

2.74

ug/l

0.50

298

Dental caries, including avohilmo

304

959

1.63

12.87

2.1

2.2

2.07

2.40

ug/l

0.95

254

804

All kidney diseases

371

1632

1.52

12.65

2.2

2.40

2.32

ug/l

0.13

294

1390

Chondropathies

264

2.63

12.55

2.6

2.1

2.42

2.54

ug/l

0.10

221

Injuries to the shoulder and upper arm

351

1772

1.53

12.49

2.2

2.37

2.32

ug/l

0.11

294

1479

Ankylosing spondylitis

121

3.41

11.77

2.4

2.2

1.88

2.17

ug/l

0.24

Injury of muscle and tendon at shoulder and upper arm level

185

1060

1.75

11.76

2.2

2.27

2.25

ug/l

0.03

157

880

Use of hypnotics and sedatives

408

1589

1.47

11.36

2.1

2.2

2.11

2.35

ug/l

0.51

343

1321

Other diseases of hard tissues of teeth

241

750

1.67

11.35

2.1

2.2

2.06

2.19

ug/l

0.26

202

631

Symptoms and signs involving cognition, perception, emotional state and behaviour

366

1663

1.47

10.65

2.2

1.91

2.42

ug/l

3.38

310

1381

Missing teeth due to accident, extraction or parodontitis

291

1703

1.53

10.64

2.3

2.2

2.76

2.27

ug/l

1.27

238

1430

Asthma, unspecified (mode), excluding more controls

218

950

1.65

10.48

2.3

2.50

2.58

ug/l

0.06

183

812

Erysipelas

261

1445

1.56

10.41

2.2

2.91

2.24

ug/l

1.10

218

1213

Atrial fibrillation and flutter

121

398

1.97

10.27

2.4

2.3

2.82

2.65

ug/l

0.09

108

348

Cardiac arrhythmias

183

684

1.72

10.13

2.5

2.2

2.55

2.51

ug/l

0.03

161

582

Sleep apnoea

372

1617

1.45

10.01

2.2

2.16

2.38

ug/l

0.69

290

1374

Factors influencing health status and contact with health services

102

241

2.13

10.00

2.2

2.3

2.05

2.04

ug/l

0.01

202

Diseases of oesophagus, stomach and duodenum

390

1600

1.44

9.95

2.2

2.24

2.32

ug/l

0.13

325

1344

Other arrhythmias

239

1129

1.58

9.95

2.4

2.2

2.25

2.31

ug/l

0.12

199

948

Gingivitis and periodontal diseases

380

1352

1.45

9.89

2.2

2.56

2.28

ug/l

0.69

322

1129

Other/unspecified rheumatoid arthritis

304

2.32

9.82

2.1

2.2

2.24

2.33

ug/l

0.08

254

Supplementary factors related to causes of morbidity and mortality classified elsewhere

128

696

1.85

9.77

2.1

2.2

2.03

2.47

ug/l

0.90

103

577

Type of accident

122

654

1.87

9.74

2.2

2.06

2.52

ug/l

0.91

544

Heart failure, not strict

331

1512

1.47

9.74

2.2

2.3

2.18

2.40

ug/l

0.53

257

1286

Sleep apnoea, including avohilmo

381

1603

1.44

9.72

2.2

2.23

2.40

ug/l

0.46

302

1358

Caries of dentine, including avohilmo

303

1024

1.52

9.65

2.1

2.2

2.00

2.41

ug/l

1.47

251

863

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

129

435

1.87

9.48

2.5

2.3

2.89

2.58

ug/l

0.19

115

381

Other and unspecified nerve root and plexus disorders, also in other diseases

419

2.09

9.46

2.6

2.2

2.71

2.47

ug/l

0.14

360

Atrial fibrillation and flutter with reimbursement

115

375

1.94

9.36

2.4

2.3

2.21

2.72

ug/l

0.80

102

326

Falls/tendency to fall

355

1223

1.46

9.29

2.3

2.2

2.23

2.27

ug/l

0.08

300

1027

Diverticular disease of intestine

312

1315

1.48

9.26

2.3

2.2

2.36

2.29

ug/l

0.09

272

1105

Other heart diseases, wide

291

1174

1.50

9.24

2.4

2.2

2.55

2.33

ug/l

0.31

249

987

Neurological diseases

263

857

1.54

9.10

2.3

2.2

2.62

2.36

ug/l

0.29

212

747

Asthma, unspecified (mode)

224

1032

1.57

8.98

2.2

2.3

2.48

2.56

ug/l

0.08

189

873

Injuries to the knee and lower leg

428

1666

1.39

8.86

2.3

2.2

2.26

2.34

ug/l

0.18

353

1394

Sequelae of other external causes

103

3.23

8.76

1.9

2.3

3.60

2.09

ug/l

0.85

Second line medication for Crohn's disease

212

1362

1.56

8.68

2.2

2.21

2.39

ug/l

0.33

175

1131

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

363

1731

1.41

8.68

2.1

2.2

2.44

2.28

ug/l

0.40

289

1461

Soft tissue disorders related to use, overuse and pressure

116

640

1.82

8.52

2.4

2.2

2.41

2.47

ug/l

0.08

529

Mycoses, including avohilmo

335

1792

1.42

8.50

2.2

2.02

2.38

ug/l

1.47

283

1496

Other disorders of ear

352

1605

1.42

8.50

2.2

2.43

2.27

ug/l

0.26

290

1346

Dizziness and giddiness

298

1597

1.45

8.45

2.3

2.2

1.94

2.45

ug/l

2.85

259

1327

Renal tubulo-interstitial diseases

330

1695

1.43

8.44

2.2

2.15

2.37

ug/l

0.60

264

1436

L04AX Other immunosuppressants

209

1349

1.55

8.42

2.2

2.24

2.40

ug/l

0.28

172

1119

First line medication for Crohn's disease

378

1448

1.41

8.38

2.2

2.34

2.36

ug/l

0.03

312

1214

Sleep disorders (combined)

402

1513

1.39

8.28

2.1

2.2

2.23

2.40

ug/l

0.45

326

1279

Pain (limb, back, neck, head abdominally)

254

841

1.52

8.17

2.2

2.37

2.18

ug/l

0.23

216

707

Certain infectious and parasitic diseases, including avohilmo

254

841

1.52

8.16

2.2

2.36

2.27

ug/l

0.09

217

697

Scoliosis

113

3.03

8.14

2.1

2.3

2.17

3.03

ug/l

0.50

Later onset COPD

926

0.45

7.95

1.7

2.1

2.31

2.07

ug/l

0.32

757

Speech therapy

118

670

1.77

7.92

2.4

2.2

2.29

2.45

ug/l

0.19

105

561

Diseases of pulp and periapical tissues and dental caries

257

881

1.50

7.89

2.2

2.04

2.42

ug/l

1.04

222

736

Diseases of oral cavity, salivary glands and jaws

224

752

1.54

7.76

2.1

2.2

1.92

2.19

ug/l

0.69

195

632

Gastro-oesophageal reflux disease

270

1571

1.45

7.76

2.3

2.2

2.16

2.32

ug/l

0.40

219

1323

Dermatophytosis, including avohilmo

246

1640

1.47

7.75

2.3

2.2

1.91

2.29

ug/l

1.66

213

1365

Sensorineural hearing loss

325

1539

1.41

7.67

2.2

2.68

2.28

ug/l

0.60

262

1289

Other diseases of intestines

342

1358

1.40

7.64

2.3

2.2

2.42

2.28

ug/l

0.20

278

1140

Symptoms and signs involving the urinary system

307

1636

1.42

7.62

2.1

2.2

2.83

2.24

ug/l

0.85

239

1383

Varicose veins

263

1366

1.46

7.57

2.3

2.2

2.58

2.27

ug/l

0.53

230

1139

Cervical disc disorders

135

807

1.68

7.54

2.3

2.2

2.26

2.32

ug/l

0.08

106

663

Chronic periodontitis, including avohilmo

373

1733

1.37

7.54

2.3

2.2

2.31

2.32

ug/l

0.03

305

1454

Radiculopathy

335

2.07

7.45

2.2

2.1

2.36

2.66

ug/l

0.28

274

Cholelithiasis, broad definition with cholecystitis

341

1634

1.39

7.45

2.2

2.02

2.41

ug/l

1.31

276

1377

Periodontitis

373

1735

1.37

7.44

2.3

2.2

2.31

2.32

ug/l

0.02

305

1455

Disorders of gallbladder, biliary tract and pancreas

372

1689

1.37

7.41

2.2

2.08

2.38

ug/l

0.92

300

1425

Pain, not elsewhere classified

113

649

1.75

7.32

2.0

2.2

2.62

2.37

ug/l

0.33

544

Cardiovascular diseases (excluding rheumatic etc)

133

444

1.72

7.31

2.2

2.3

2.22

2.60

ug/l

0.62

110

386

Myalgia

431

1.91

7.09

2.5

2.3

2.28

2.61

ug/l

0.41

358

Abnormalities of breathing

290

1167

1.42

7.06

2.3

2.2

1.94

2.35

ug/l

1.77

230

984

Conductive and sensorineural hearing loss

326

1563

1.39

7.03

2.2

2.70

2.27

ug/l

0.67

261

1309

Hypertensive diseases (excluding secondary)

129

441

1.70

6.98

2.2

2.3

2.00

2.61

ug/l

1.23

104

384

Hernia

331

1595

1.38

6.96

2.2

2.32

2.39

ug/l

0.16

281

1323

Polycystic ovarian syndrome, consortium definition

196

734

1.53

6.94

2.1

2.3

2.86

2.75

ug/l

0.09

160

637

Disorders of muscles

195

2.37

6.93

2.3

1.86

2.73

ug/l

1.05

160

Any death

153

1666

0.64

6.87

1.7

2.3

2.78

2.28

ug/l

0.41

125

1397

Medical observation and evaluation for suspected diseases and conditions

221

755

1.50

6.85

2.1

2.3

2.34

2.30

ug/l

0.04

176

649

Injury of muscle and tendon at lower leg level

327

2.03

6.79

2.6

2.2

2.52

2.32

ug/l

0.16

273

Impingement syndrome of shoulder

100

568

1.77

6.78

2.4

2.2

2.01

2.46

ug/l

1.00

465

Obesity due to excess calories

155

988

1.57

6.74

2.3

2.2

2.47

2.32

ug/l

0.16

123

819

Disorders of choroid and retina

333

1705

1.37

6.73

2.1

2.2

2.08

2.38

ug/l

0.71

270

1434

Caries of dentine

443

1.86

6.72

2.2

2.03

2.24

ug/l

0.22

366

Hyperplasia of prostate

165

588

1.58

6.70

2.2

2.1

2.29

1.76

ug/l

0.92

130

497

Intracranial trauma

167

722

1.56

6.68

2.3

2.2

2.31

2.36

ug/l

0.07

136

633

Ankylosing spondylitis, ICD10

162

2.48

6.67

2.4

2.2

1.88

2.15

ug/l

0.23

139

Biological medication for rheuma

269

2.13

6.66

2.3

2.2

2.39

2.59

ug/l

0.16

226

Congenital malformations, deformations and chromosomal abnormalities

163

998

1.55

6.62

2.2

2.62

2.34

ug/l

0.25

135

831

Presence of cardiac and vascular implants and grafts

184

893

1.52

6.54

2.3

2.2

2.69

2.13

ug/l

0.57

154

737

Dental caries

499

1.78

6.52

2.2

2.01

2.19

ug/l

0.21

414

Diseases of male genital organs

186

610

1.54

6.51

2.5

2.1

2.15

1.75

ug/l

0.97

148

514

Obesity

208

1336

1.47

6.51

2.2

2.3

2.46

2.31

ug/l

0.20

164

1122

Obesity and other hyperalimentation

209

1343

1.46

6.48

2.2

2.46

2.30

ug/l

0.20

165

1129

Disorders of eyelid, lacrimal system and orbit

325

1748

1.36

6.48

2.1

2.2

2.60

2.30

ug/l

0.42

275

1460

Cholelithiasis

323

1616

1.37

6.43

2.2

2.06

2.40

ug/l

1.05

261

1360

Diseases of the skin and subcutaneous tissue

347

1280

1.36

6.41

2.2

2.45

2.28

ug/l

0.24

287

1077

Other postsurgical states

102

2.86

6.36

2.2

3.43

2.09

ug/l

0.75

Other disorders of veins

160

1035

1.52

6.09

2.4

2.2

2.63

2.31

ug/l

0.47

134

860

General examination and investigation of persons without complaint and reported diagnosis

213

755

1.47

6.04

2.1

2.3

2.30

ug/l

0.00

172

649

214

1341

1.44

6.03

2.2

2.26

2.33

ug/l

0.12

181

1114

Persons encountering health services in other circumstances, wide

407

1594

1.31

5.98

2.0

2.3

1.89

2.39

ug/l

3.27

335

1343

Other/unspecified synovitis and tenosynovitis

222

2.17

5.95

2.2

2.3

2.69

2.87

ug/l

0.10

183

Oedema, not elsewhere classified

150

955

1.54

5.95

2.2

2.36

2.27

ug/l

0.08

109

792

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

841

0.46

5.94

1.7

2.2

1.93

2.34

ug/l

0.68

707

Excessive attrition of teeth

195

1331

1.45

5.87

2.4

2.2

2.48

2.29

ug/l

0.34

167

1112

Other enthesopathies

100

594

1.69

5.83

2.5

2.2

2.98

2.55

ug/l

0.23

495

Other condition

278

2.02

5.79

2.1

2.2

2.47

2.55

ug/l

0.05

233

COPD, early/later onset

104

1416

0.61

5.78

2.0

2.2

2.92

2.20

ug/l

0.45

1174

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

225

2.15

5.78

2.5

2.2

2.60

2.15

ug/l

0.60

191

Constipation

334

1698

1.33

5.76

2.2

2.42

2.29

ug/l

0.18

270

1431

L04AA Selective immunosuppressants

450

1.78

5.68

2.4

2.2

2.50

2.58

ug/l

0.07

377

Cerebrovascular diseases (FINNGEN)

403

1.71

5.64

2.6

2.3

2.82

2.62

ug/l

0.16

352

Conduction disorders

143

744

1.54

5.63

2.2

2.1

2.50

2.29

ug/l

0.14

117

624

COPD, hospital admissions

103

1400

0.62

5.61

2.0

2.2

2.92

2.20

ug/l

0.45

1159

Continuous positive airway pressure

355

1.81

5.60

2.1

2.2

2.40

2.46

ug/l

0.05

307

Persons encountering health services for other counselling and medical advice, not elsewhere classified

391

1592

1.31

5.58

2.0

2.3

2.02

2.39

ug/l

1.64

320

1342

Pain in throat and chest

270

1166

1.37

5.48

2.3

2.2

2.60

2.35

ug/l

0.34

230

983

Presence of other devices

102

610

1.65

5.48

2.1

2.88

2.22

ug/l

0.86

502

Other nutritional deficiencies

216

1406

1.40

5.41

2.2

2.76

2.26

ug/l

0.52

171

1183

Other cataract

193

999

1.44

5.35

2.2

2.32

2.45

ug/l

0.11

161

831

Actinic keratosis

198

1268

1.42

5.34

2.2

2.16

2.28

ug/l

0.24

165

1052

Skin changes due to chronic exposure to nonionizing radiation

202

1292

1.42

5.34

2.2

2.15

2.27

ug/l

0.22

169

1073

Bleeding

321

1704

1.32

5.28

2.1

2.2

2.26

2.34

ug/l

0.13

261

1430

Other/unspecified dorsalgia

114

712

1.58

5.22

2.2

2.1

2.19

2.43

ug/l

0.37

584

Contracture of joint

+∞

5.21

2.6

0.0

1.22

—

ug/l

—

Cardiovascular diseases

110

358

1.63

5.10

2.1

2.2

2.30

2.61

ug/l

0.36

311

Certain infectious and parasitic diseases

316

1196

1.32

4.99

2.3

2.2

2.81

2.18

ug/l

1.18

269

1002

Hard cardiovascular diseases

297

1322

1.33

4.95

2.3

2.70

2.36

ug/l

0.51

241

1113

Obesity related asthma

129

851

1.52

4.95

2.3

2.2

1.91

2.42

ug/l

1.61

111

700

Biomechanical lesions, not elsewhere classified

106

2.57

4.88

2.2

2.3

1.73

2.05

ug/l

0.46

COPD, hospital admissions 1, only main diagnosis

1071

0.59

4.88

2.1

2.2

3.25

2.14

ug/l

0.51

879

Any gastric operation

212

757

1.41

4.87

2.1

2.3

2.58

2.35

ug/l

0.19

178

650

GASTRO-related operations

212

757

1.41

4.87

2.1

2.3

2.58

2.35

ug/l

0.19

178

650

Autoimmune diseases excluding thyroid diseases

349

1458

1.30

4.86

2.2

2.20

2.30

ug/l

0.24

289

1236

Autoimmune diseases excluding thyroid diseases, strict definition

339

1419

1.30

4.79

2.2

2.23

2.29

ug/l

0.13

279

1201

Dislocation, sprain and strain of joints and ligaments of knee

175

1112

1.42

4.79

2.3

2.2

1.92

2.31

ug/l

1.39

148

929

COPD related to multimorbidity

1285

0.64

4.73

2.0

2.2

2.86

2.14

ug/l

0.41

1062

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

302

1557

1.31

4.69

2.1

2.3

2.16

2.41

ug/l

0.62

253

1310

Non-rheumatic valve diseases

192

978

1.40

4.67

2.2

2.1

2.23

2.37

ug/l

0.26

166

820

Valvular heart disease excluding rheumatic fever

192

979

1.40

4.66

2.2

2.1

2.23

2.37

ug/l

0.26

166

821

Other disorders of urethra and urinary system

255

1325

1.34

4.66

2.2

2.37

2.38

ug/l

0.02

205

1107

Other abnormal uterine and vaginal bleeding

301

1.75

4.64

2.2

2.3

3.58

2.64

ug/l

0.39

259

Injuries to the head

368

1711

1.28

4.61

2.3

2.2

2.32

2.33

ug/l

0.00

295

1447

Sequelae of injuries, of poisoning and of other consequences of external causes

495

1.66

4.60

2.5

2.3

2.33

2.46

ug/l

0.12

418

Lesion of ulnar nerve

275

1.90

4.57

2.1

2.2

2.34

2.21

ug/l

0.08

236

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

176

1140

1.41

4.54

2.2

2.55

2.34

ug/l

0.19

146

944

Sequelae of injuries of lower limb

180

2.12

4.53

2.4

2.3

2.75

2.25

ug/l

0.32

155

Overexertion and strenuous or repetitive movements

187

2.10

4.51

2.1

2.3

4.00

2.14

ug/l

0.50

160

Concussion

137

719

1.48

4.50

2.2

2.29

2.36

ug/l

0.10

118

630

Later onset COPD, excluding more controls

668

0.53

4.49

1.7

2.2

2.41

2.31

ug/l

0.10

557

Follow-up examination after treatment for conditions other than malignant neoplasms

147

669

1.47

4.49

2.4

2.3

2.48

2.36

ug/l

0.15

113

571

Pure hypercholesterolaemia

300

1464

1.30

4.44

2.3

2.2

2.05

2.42

ug/l

1.33

247

1232

Other disorders of skin and subcutaneous tissue

274

1766

1.31

4.44

2.2

2.54

2.31

ug/l

0.31

225

1481

Obesity, other/unspecified

594

1.59

4.41

2.1

2.3

2.32

2.46

ug/l

0.14

502

Misadventures to patients during surgical and medical care

272

1.88

4.38

2.1

2.2

3.34

1.91

ug/l

1.35

227

Other and unspecified iron deficiency

138

949

1.45

4.32

2.0

2.2

2.44

2.41

ug/l

0.04

107

793

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

302

1824

1.29

4.31

2.2

2.25

2.34

ug/l

0.16

254

1526

ILD medications: azathioprine

239

1.93

4.28

2.3

2.49

2.61

ug/l

0.06

202

Hypertension, essential

225

943

1.35

4.21

2.2

2.38

2.49

ug/l

0.10

181

804

Other chronic obstructive pulmonary disease

103

1270

0.66

4.20

2.0

2.2

2.92

2.22

ug/l

0.44

1051

Heart failure and antihypertensive medication

354

1.62

4.19

2.2

2.20

2.52

ug/l

0.34

303

AV-block

505

1.58

4.18

2.3

2.0

1.96

2.11

ug/l

0.32

414

Spondyloarthritis

357

1.74

4.17

2.3

2.2

1.72

2.37

ug/l

0.99

300

Fissure and fistula of anal and rectal regions

572

1.58

4.15

2.3

2.2

2.86

2.44

ug/l

0.26

478

Sulfonylureas

1026

0.63

4.13

2.2

2.41

2.29

ug/l

0.07

858

Fever of other and unknown origin

199

1272

1.36

4.13

2.1

2.3

2.24

2.30

ug/l

0.10

167

1069

Other diseases of urinary system

334

1474

1.27

4.10

2.2

2.24

2.32

ug/l

0.14

268

1238

Benign neoplasms

301

1270

1.29

4.10

2.2

2.13

2.38

ug/l

0.55

244

1066

Hypertensive diseases

224

943

1.34

4.03

2.3

2.2

2.41

2.49

ug/l

0.07

183

804

Hypertension

224

943

1.34

4.03

2.3

2.2

2.41

2.49

ug/l

0.07

183

804

Sub-endpoint used in defining T1D endpoints

583

0.47

4.03

2.4

2.2

2.20

2.23

ug/l

0.01

478

Implicit Sepsis, including avohilmo

294

1638

1.28

4.01

2.1

2.3

2.24

2.35

ug/l

0.22

243

1380

Other diseases of lip and oral mucosa

149

1059

1.41

3.98

2.3

2.2

2.21

2.43

ug/l

0.43

117

888

Fentanyl

176

2.05

3.97

1.8

2.1

2.22

2.10

ug/l

0.11

145

Unspecified urinary incontinence

204

1.97

3.96

2.3

2.1

1.99

2.33

ug/l

0.47

177

Hypothyroidism (congenital or acquired)

140

1.92

3.96

2.2

2.3

2.95

2.81

ug/l

0.06

119

Leisure time condition

402

1.67

3.91

2.2

1.70

2.26

ug/l

1.47

339

Impotence

125

2.25

3.90

2.1

2.29

1.80

ug/l

0.25

103

Hydrocele

313

1.76

3.89

2.3

2.1

2.47

1.83

ug/l

0.52

261

Iron deficiency anaemia

170

1217

1.37

3.88

2.0

2.2

2.38

2.31

ug/l

0.12

127

1019

Azathioprine

248

1.86

3.87

2.3

2.2

2.49

2.56

ug/l

0.04

208

Other special examinations and investigations of persons without complaint or reported diagnosis

202

755

1.36

3.86

2.2

2.3

2.24

2.30

ug/l

0.06

167

649

Episodal and paroxysmal disorders

337

1354

1.26

3.85

2.2

2.34

2.38

ug/l

0.06

268

1152

Fracture of neck

152

2.12

3.84

2.5

2.3

2.19

2.01

ug/l

0.16

125

Ischemic heart diseases

296

1383

1.28

3.76

2.3

2.2

2.73

2.33

ug/l

0.56

237

1162

Persons encountering health services for examination and investigation

203

755

1.35

3.76

2.2

2.3

1.99

2.30

ug/l

0.78

170

649

Condition for Implicit Sepsis (Organ dysfunction codes)

297

1621

1.27

3.75

2.1

2.2

2.27

2.36

ug/l

0.17

244

1364

Used for control exclusion in common control thyroid runs

337

1351

1.26

3.74

2.1

2.2

2.48

2.23

ug/l

0.37

278

1144

Disorders of lens

247

1177

1.30

3.73

2.3

2.2

2.50

2.38

ug/l

0.11

202

985

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

318

1.55

3.73

2.2

2.10

2.52

ug/l

0.59

270

Other/unspecified enthesopathies, not elsewhere classified

168

2.03

3.69

2.3

4.32

2.65

ug/l

0.33

139

All pneumoniae

325

1684

1.25

3.67

2.1

2.3

2.36

ug/l

0.00

264

1423

Gluteal tendinitis

2.70

3.66

2.0

2.3

2.35

2.77

ug/l

0.25

Examination and observation for other reasons

182

755

1.36

3.66

1.9

2.3

2.23

2.30

ug/l

0.10

144

649

Ovarian cyst

308

1.58

3.65

2.2

2.3

4.71

2.64

ug/l

0.97

266

Traumatic subdural haemorrhage

355

1.67

3.62

2.2

2.1

2.09

2.08

ug/l

0.01

304

Asthma (diagnoses ohter than nonallergic)

287

1834

1.26

3.60

2.2

2.27

2.35

ug/l

0.09

244

1530

Haemorrhoids and perianal venous thrombosis

138

980

1.40

3.60

2.2

2.1

2.46

2.33

ug/l

0.14

108

814

Non-selective monoamine reuptake inhibitors

142

980

1.39

3.57

2.1

2.2

2.00

2.48

ug/l

1.44

120

821

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

742

0.60

3.56

1.9

2.2

1.74

2.19

ug/l

0.98

620

Other noninflammatory disorders of uterus, except cervix

302

1.62

3.55

2.1

2.3

3.04

2.63

ug/l

0.16

260

Influenza and pneumonia

333

1651

1.24

3.51

2.1

2.3

2.36

ug/l

0.01

271

1394

Systemic connective tissue disorders

128

909

1.41

3.49

2.2

2.15

2.46

ug/l

0.58

101

767

Other neurological diseases

280

1719

1.26

3.49

2.3

2.2

2.41

2.32

ug/l

0.11

233

1434

Chronic iridocyclitis

2.38

3.48

2.2

1.94

2.06

ug/l

0.06

Pneumonias (Asthma/COPD co-morbidities)

322

1687

1.25

3.48

2.1

2.3

2.34

2.35

ug/l

0.02

261

1426

Symptoms and signs involving the skin and subcutaneous tissue

245

1808

1.28

3.48

2.3

2.2

2.55

2.30

ug/l

0.31

206

1515

Temporomandibular joint disorders, including avohilmo

106

704

1.46

3.47

2.3

2.22

2.54

ug/l

0.42

599

Other bursopathies

317

1.71

3.46

2.2

2.09

2.70

ug/l

0.81

257

Glaucoma suspect

153

1121

1.37

3.46

2.4

2.2

2.31

2.42

ug/l

0.15

125

934

COPD

112

1294

0.70

3.45

2.0

2.2

2.86

2.23

ug/l

0.43

1071

Bacterial infection, other or unspecified, including avohilmo

226

1433

1.29

3.42

2.0

2.2

2.10

2.27

ug/l

0.38

187

1196

Hypothyroidism and >3 levothyroxin purchases

140

1.84

3.41

2.1

2.3

2.99

2.81

ug/l

0.08

119

Hypothyroidism, levothyroxine purchases

140

1.84

3.41

2.1

2.3

2.99

2.81

ug/l

0.08

119

Diseases of arteries, arterioles and capillaries (FINNGEN)

354

1.56

3.41

2.3

3.48

2.76

ug/l

0.25

308

Other and unspecified local infections of skin and subcutaneous tissue

209

1.87

3.39

2.0

2.2

3.68

2.24

ug/l

0.49

177

Fall on same level involving ice and snow

200

1532

1.31

3.35

2.3

2.2

2.42

2.38

ug/l

0.06

170

1272

Paroxysmal tachycardia

340

1.62

3.35

2.2

2.3

2.29

2.73

ug/l

0.46

295

Injuries to the abdomen, lower back, lumbar spine and pelvis

145

1045

1.37

3.34

2.3

2.2

2.39

ug/l

0.00

126

867

Polyp of the female genital tract

308

1.55

3.32

2.3

3.01

2.64

ug/l

0.17

266

Cholecystectomy

254

1704

1.27

3.29

2.3

2.2

2.14

2.41

ug/l

0.58

214

1419

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

316

1698

1.24

3.28

2.1

2.3

2.38

2.36

ug/l

0.03

256

1436

Venous thromboembolism

213

1590

1.29

3.27

2.2

2.37

2.32

ug/l

0.09

164

1335

Malignant neoplasm of bronchus and lung, including Hilmo

671

0.59

3.25

1.8

2.2

1.87

2.19

ug/l

0.53

559

Inguinal hernia

211

1079

1.30

3.25

2.2

1.95

2.21

ug/l

0.73

183

885

Insulin, combination of fast acting with intermediate-acting or long-acting

135

1668

0.73

3.24

2.2

1.88

2.27

ug/l

1.30

109

1395

Other local infections of skin and subcutaneous tissue

220

1.83

3.22

2.0

2.2

3.66

2.19

ug/l

0.52

186

Chronic apical periodontitis

363

1666

1.22

3.22

2.2

2.48

2.29

ug/l

0.44

295

1403

Redundant prepuce, phimosis and paraphimosis

411

1.58

3.18

2.4

2.1

3.19

1.78

ug/l

1.08

344

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

651

1.46

3.18

2.2

2.47

2.46

ug/l

0.01

536

Open wound of lower leg

326

1.66

3.16

2.5

2.2

2.58

2.60

ug/l

0.01

276

Convalescence

104

2.22

3.16

2.3

2.2

2.31

2.21

ug/l

0.07

Fracture of lumbar spine and pelvis

643

1.46

3.14

2.3

2.1

2.17

2.31

ug/l

0.19

533

Chronic ulcer of skin, not elsewhere classified

172

1.93

3.14

2.3

2.91

1.92

ug/l

0.62

146

Emergency coronary revascularization (for ACS)

308

1503

1.24

3.13

2.3

2.2

2.70

2.32

ug/l

0.57

248

1259

Unspecified misadventure during surgical and medical care

131

2.07

3.12

2.0

2.3

4.25

1.93

ug/l

1.25

114

Disorders of lacrimal system

155

1140

1.34

3.12

2.3

3.00

2.43

ug/l

0.40

129

951

Percutaneous Coronary Intervention

282

1374

1.25

3.11

2.3

2.2

2.82

2.33

ug/l

0.73

228

1155

Undetermined asthma, excluding more controls

312

1.67

3.10

2.2

1.87

2.80

ug/l

1.66

268

Cardiodefibrillation

163

1226

1.33

3.10

2.2

2.00

2.18

ug/l

0.35

141

1012

Malignant neoplasm of respiratory system and intrathoracic organs

668

0.61

3.09

1.8

2.2

1.79

2.18

ug/l

0.69

555

Other disorders of bladder

353

1.62

3.04

2.0

2.1

1.47

1.97

ug/l

1.54

287

Other skin changes

568

1.48

3.03

2.4

2.1

2.45

2.41

ug/l

0.04

471

Exclusions for E4_PCOS_CONSORTIUM

180

854

1.32

3.03

2.3

2.40

2.64

ug/l

0.39

150

729

Other aneurysm

147

1.99

3.00

1.8

2.3

1.74

1.90

ug/l

0.23

128

Basal cell carcinoma

209

1110

1.29

2.99

2.2

2.44

2.42

ug/l

0.03

177

927

Transport accidents

120

720

1.39

2.98

2.4

2.1

2.34

2.00

ug/l

0.29

600

Benzodiazepine use

327

1809

1.22

2.98

2.2

2.32

2.33

ug/l

0.01

268

1517

COPD, hospital admissions 3, with asthma pneumonia sepsis

839

0.65

2.96

1.9

2.1

3.27

2.08

ug/l

0.48

681

Unspecified haematuria

178

1111

1.31

2.96

2.0

2.2

2.28

2.19

ug/l

0.11

140

933

Implicit Sepsis

275

1636

1.24

2.93

2.1

2.3

2.18

2.37

ug/l

0.38

226

1379

Other functional intestinal disorders

162

1118

1.32

2.92

2.2

2.1

2.35

2.34

ug/l

0.01

130

933

Coronary revascularization (ANGIO or CABG)

280

1374

1.24

2.90

2.3

2.2

2.84

2.33

ug/l

0.75

226

1155

Hernia of abdominal wall, postoperative

465

1.52

2.89

2.2

2.10

2.28

ug/l

0.27

394

Colonic or urogenital fistula

648

1.44

2.89

2.3

2.2

2.83

2.44

ug/l

0.24

537

Pacemaker

165

1171

1.31

2.88

2.2

2.1

1.94

2.20

ug/l

0.89

132

968

Fitting and adjustment of other devices

159

1063

1.32

2.88

2.0

2.2

3.26

2.28

ug/l

1.19

118

896

Acute tubulo-interstitial nephritis

226

1514

1.26

2.87

2.2

2.15

2.37

ug/l

0.57

181

1277

Insulin, fast-acting or short human

958

0.66

2.87

2.0

2.2

1.73

2.34

ug/l

1.39

779

Glaucoma

238

1615

1.25

2.87

2.3

2.2

2.33

2.39

ug/l

0.10

195

1345

Other chronic obstructive pulmonary disease, including avohilmo

144

1564

0.75

2.86

2.0

2.2

2.64

2.22

ug/l

0.32

119

1302

Insulin, fast-acting

957

0.66

2.86

2.0

2.1

1.73

2.35

ug/l

1.44

786

Basal cell carcinoma, including Hilmo

213

1134

1.27

2.85

2.2

2.43

ug/l

0.00

180

945

Transient global amnesia

252

1.71

2.84

2.3

2.05

2.28

ug/l

0.23

212

Leiomyoma of uterus

167

710

1.32

2.84

2.3

2.47

2.84

ug/l

0.63

144

606

Other retinal disorders

256

1566

1.24

2.84

2.1

2.2

2.11

2.38

ug/l

0.56

213

1313

Mycoses

701

1.42

2.83

2.1

2.2

2.04

2.43

ug/l

0.73

581

Schizophrenia or delusion

584

0.56

2.82

2.4

2.2

1.53

2.49

ug/l

2.60

493

Senile cataract

237

1147

1.26

2.81

2.4

2.2

2.55

2.39

ug/l

0.15

197

958

Covid-19 confirmed case

142

1066

1.33

2.81

2.3

2.1

2.11

2.36

ug/l

0.49

119

882

Candidiasis, including avohilmo

670

1.42

2.78

2.1

2.2

2.11

2.50

ug/l

0.70

569

Anaemias

140

1.79

2.77

2.5

2.3

2.63

2.81

ug/l

0.07

119

Menorrhagia

308

1.49

2.76

2.2

2.3

2.53

2.64

ug/l

0.11

266

Infections of the skin and subcutaneous tissue

180

1379

1.29

2.75

2.2

2.48

2.26

ug/l

0.23

148

1150

Genitourinary diseases

158

599

1.32

2.70

2.4

2.2

2.15

1.99

ug/l

0.26

135

512

Any reimbursement code in KELA

130

478

1.36

2.70

2.1

2.3

2.33

2.41

ug/l

0.08

107

411

Major coronary heart disease event

297

1457

1.22

2.69

2.3

2.2

2.82

2.32

ug/l

0.77

242

1221

Undetermined asthma

326

1.60

2.66

2.2

1.87

2.75

ug/l

1.57

275

Depression or dysthymia

235

1026

1.25

2.66

2.2

1.95

2.42

ug/l

1.93

196

862

Malignant neoplasm of bronchus and lung

584

0.61

2.64

1.7

2.1

1.94

2.19

ug/l

0.32

483

COPD, hospital admission 2, with asthma infections

994

0.70

2.64

2.0

2.1

3.04

2.10

ug/l

0.47

814

Pneumonia, organism unspecified

291

1641

1.22

2.62

2.1

2.3

2.35

2.36

ug/l

0.01

232

1386

Other spirochaetal diseases, including avohilmo

118

873

1.35

2.62

2.3

2.2

3.25

2.37

ug/l

0.87

728

Other malignant neoplasms of skin (=non-melanoma skin cancer)

209

1129

1.26

2.57

2.2

2.55

2.44

ug/l

0.18

180

942

General symptoms and signs

325

1351

1.21

2.55

2.2

2.3

2.59

2.30

ug/l

0.44

272

1139

Other female pelvic inflammatory diseases

299

1.61

2.55

1.9

2.2

2.70

3.03

ug/l

0.20

261

Unspecified privation

215

1.73

2.55

2.2

1.92

2.17

ug/l

0.33

183

Other disorders of lacrimal gland

124

929

1.34

2.55

2.2

2.3

3.26

2.38

ug/l

0.51

103

773

COPD (mode)

858

0.70

2.54

2.0

2.2

3.43

2.44

ug/l

0.47

718

Benign neoplasm of colon, rectum, anus and anal canal

256

1770

1.22

2.53

2.2

2.32

2.35

ug/l

0.04

209

1481

Haemorrhage from respiratory passages

139

936

1.32

2.53

2.0

2.2

2.36

2.24

ug/l

0.20

114

786

Symptoms and signs involving the circulatory and respiratory systems

284

1167

1.22

2.52

2.3

2.2

2.54

2.35

ug/l

0.21

240

984

Disorders of lipoprotein metabolism and other lipidaemias

295

1482

1.21

2.51

2.2

2.23

2.43

ug/l

0.42

242

1247

DVT of lower extremities and pulmonary embolism

162

1257

1.28

2.50

2.2

2.33

2.32

ug/l

0.02

121

1047

Schizophrenia or delusion, excluding more controls

555

0.59

2.49

2.4

2.3

1.53

2.41

ug/l

2.48

469

Zoster [herpes zoster], including avohilmo

199

1535

1.25

2.48

2.2

2.25

2.39

ug/l

0.23

164

1279

Cervicalgia

381

1.53

2.46

2.0

2.2

2.57

2.65

ug/l

0.03

317

Gastrointestinal diseases

150

573

1.31

2.46

2.2

2.52

2.25

ug/l

0.22

125

469

Open wound of ankle and foot

218

1.70

2.44

2.1

2.3

2.82

2.00

ug/l

0.91

186

Other systemic involvement of connective tissue

688

1.38

2.44

2.1

2.2

2.11

2.51

ug/l

0.63

586

Diseases of the eye and adnexa

196

777

1.26

2.42

2.2

2.3

1.87

2.35

ug/l

1.55

164

657

Excessive, frequent and irregular menstruation

308

1.44

2.41

2.0

2.3

2.87

2.64

ug/l

0.10

266

290

1404

1.21

2.41

2.1

2.3

2.36

ug/l

0.00

233

1181

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

290

1404

1.21

2.41

2.1

2.3

2.36

ug/l

0.00

233

1181

Pulmonary embolism

115

860

1.34

2.41

2.3

2.2

2.20

2.41

ug/l

0.31

715

Ascites

207

0.39

2.40

2.0

2.2

2.90

2.02

ug/l

—

169

Other antidepressants

333

1425

1.19

2.38

2.2

2.29

2.31

ug/l

0.02

268

1201

Benign neoplasm: Colon

222

1694

1.23

2.38

2.2

2.27

2.32

ug/l

0.08

183

1408

Malaise and fatigue

189

1186

1.26

2.37

2.0

2.2

2.25

2.29

ug/l

0.06

152

990

Fall on and from stairs and steps

641

1.39

2.37

2.3

2.2

2.53

2.46

ug/l

0.05

536

Pulmonary heart disease, diseases of pulmonary circulation

126

958

1.32

2.36

2.2

2.21

2.40

ug/l

0.31

797

Pulmonary heart disease

115

863

1.33

2.36

2.3

2.2

2.20

2.41

ug/l

0.31

718

Fall on and from ladder

198

1.73

2.35

2.2

2.3

1.96

1.88

ug/l

0.10

165

Other diseases of upper respiratory tract

361

1591

1.18

2.34

2.3

2.2

2.04

2.43

ug/l

1.82

293

1346

Insulin medication

135

1448

0.77

2.34

2.2

1.88

2.32

ug/l

1.53

109

1217

Spirochaetal infections, other/unspecified, including avohilmo

115

865

1.33

2.33

2.3

2.2

3.33

2.37

ug/l

0.94

720

Bacterial infection, other or unspecified

205

1396

1.24

2.33

2.0

2.2

2.16

2.27

ug/l

0.21

169

1168

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

660

0.63

2.30

1.7

2.2

1.86

2.30

ug/l

0.65

548

Other spirochaetal diseases

115

868

1.33

2.29

2.3

2.2

3.33

2.37

ug/l

0.94

723

Schizophrenia, schizotypal and delusional disorders

585

0.61

2.28

2.3

2.2

1.48

2.49

ug/l

2.99

494

Other disorders of nervous system

163

1.79

2.27

2.4

2.2

1.80

2.12

ug/l

0.31

142

Cervicobrachial syndrome

373

1.50

2.26

2.4

2.2

2.77

2.70

ug/l

0.04

310

Lateral epicondylitis

231

1.65

2.25

2.2

2.3

2.38

2.78

ug/l

0.31

192

Endometriosis

308

1.44

2.24

2.2

2.3

2.86

2.64

ug/l

0.07

266

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

210

1149

1.23

2.24

2.2

2.59

2.42

ug/l

0.27

177

957

Osteoporosis

106

728

1.34

2.23

2.2

3.16

2.45

ug/l

0.42

616

Lyme disease, including avohilmo

114

863

1.32

2.23

2.3

2.2

3.35

2.38

ug/l

0.96

718

Lyme disease

114

863

1.32

2.23

2.3

2.2

3.35

2.38

ug/l

0.96

718

Lung cancer and mesothelioma

628

0.66

2.23

1.9

2.2

1.85

2.34

ug/l

1.01

527

Other and unspecified injuries of lower leg

128

1.88

2.21

1.9

2.3

2.56

2.71

ug/l

0.04

111

Insulin, intermediate and long-acting

128

1591

0.77

2.21

2.2

1.85

2.28

ug/l

1.49

103

1330

Persons encountering health services in other circumstances

124

941

1.31

2.20

2.2

2.01

2.47

ug/l

1.10

778

Malignant neoplasm of skin, including Hilmo

218

1191

1.23

2.20

2.1

2.2

2.27

2.39

ug/l

0.21

186

995

Depression medications

140

1.62

2.20

2.1

2.3

1.87

2.81

ug/l

0.81

119

Stenosis and insufficiency of lacrimal passages

210

1.67

2.19

2.4

2.3

2.09

2.66

ug/l

0.52

176

Valvular operations

401

1.48

2.18

2.2

2.0

2.18

2.05

ug/l

0.15

326

Asthma, excluding more controls

228

956

1.22

2.17

2.3

2.21

2.57

ug/l

0.47

196

817

Asthma (mode)

242

1046

1.22

2.16

2.3

2.20

2.56

ug/l

0.49

208

883

Viral pneumonia (unknown virus, not influenza)

122

1.89

2.16

1.9

2.3

1.54

2.05

ug/l

0.79

104

Other and unspecified polyneuropathies, also in other diseases

560

1.40

2.15

2.2

1.63

2.36

ug/l

2.08

460

Unspecified fall

172

1354

1.25

2.14

2.3

2.2

2.65

2.31

ug/l

0.38

143

1127

Ganglion

370

1.49

2.13

2.3

1.59

2.79

ug/l

3.27

304

Syncope and collapse

170

1135

1.25

2.13

2.1

2.2

2.18

2.31

ug/l

0.23

140

947

Autoimmune diseases

340

1466

1.18

2.13

2.1

2.2

2.41

2.30

ug/l

0.15

275

1241

Statin medication

164

730

1.27

2.13

2.3

2.2

2.29

2.35

ug/l

0.08

135

619

Degeneration of macula and posterior pole

218

1381

1.22

2.13

2.1

2.2

1.99

2.38

ug/l

1.14

182

1161

100

698

1.34

2.12

2.1

1.68

2.32

ug/l

2.53

582

Chronic sinusitis

125

966

1.29

2.10

2.2

2.24

2.43

ug/l

0.34

808

Other CVD (FINNGEN)

226

1.56

2.10

2.1

2.2

2.06

2.41

ug/l

0.31

199

Other diseases of intestine

446

1.44

2.09

2.1

2.2

1.62

2.49

ug/l

2.49

371

Malignant neoplasm of skin

212

1176

1.22

2.07

2.2

2.43

2.39

ug/l

0.05

185

981

Atherosclerosis, excluding cerebral and coronary sclerosis

121

1223

0.78

2.06

2.0

2.2

3.10

2.15

ug/l

0.59

1023

Carcinoma in situ of skin of other and unspecified parts of face

262

1.57

2.03

2.2

1.76

1.88

ug/l

0.13

221

Spinal enthesopathy

3.08

2.01

2.0

2.3

1.07

1.78

ug/l

—

Other general symptoms and signs

2.16

2.00

2.7

2.4

3.13

2.60

ug/l

0.26

STROKE

187

1023

1.23

1.99

2.4

2.3

2.64

2.42

ug/l

0.20

158

864

Septicaemia

166

1222

1.24

1.96

1.9

2.2

2.22

2.26

ug/l

0.05

133

1024

Asthma

242

1038

1.20

1.96

2.3

2.27

2.56

ug/l

0.37

208

878

Nutritional anaemias

184

1434

1.22

1.95

2.0

2.2

2.34

2.32

ug/l

0.04

139

1196

Dental pulpitis, including avohilmo

179

1404

0.82

1.95

2.3

2.2

2.03

2.35

ug/l

1.00

154

1165

Acute upper respiratory infections of multiple and unspecified sites

154

1391

0.81

1.90

2.3

2.2

2.09

2.34

ug/l

0.56

136

1147

Gout, FINNGEN

124

968

1.27

1.89

2.3

2.1

2.37

1.98

ug/l

0.51

108

797

Fracture of lower leg, including ankle

169

1350

1.23

1.89

2.2

2.11

2.39

ug/l

0.85

138

1128

Benign neoplasm: Caecum

316

1.49

1.87

2.4

2.2

1.74

2.17

ug/l

0.78

265

Trochanteric bursitis

324

1.48

1.87

2.3

2.92

2.67

ug/l

0.20

275

Inflammatory diseases of prostate (prostatitis)

341

1.47

1.86

2.3

2.1

1.57

1.89

ug/l

0.96

286

Intracranial injury

190

1461

1.21

1.85

2.2

2.31

2.24

ug/l

0.12

157

1232

Asthma, including avohilmo

366

1747

1.15

1.85

2.2

2.16

2.36

ug/l

0.36

309

1453

Neuromuscular dysfunction of bladder

221

1.59

1.84

2.6

2.2

2.45

2.18

ug/l

0.21

185

Polyuria

699

1.32

1.82

2.4

2.2

3.29

2.19

ug/l

0.58

579

Deviated nasal septum

111

864

1.28

1.82

2.4

2.2

1.79

2.32

ug/l

1.25

722

Candidiasis

302

1.49

1.81

2.0

2.2

1.96

2.44

ug/l

0.73

256

Erosion of teeth , including avohilmo

451

1.40

1.81

2.6

2.2

2.61

2.53

ug/l

0.07

373

Striking against or struck by other objects

655

1.33

1.81

2.4

2.2

2.17

2.41

ug/l

0.34

537

Diseases of inner ear

197

1565

1.21

1.81

2.3

2.2

2.46

2.34

ug/l

0.10

165

1303

Somatoform disorder

319

1.48

1.80

2.1

2.3

1.75

2.34

ug/l

0.86

276

Vocal cord dysfunction

216

1.55

1.79

2.2

1.54

2.66

ug/l

2.23

182

Kela-code for severe mental illness

727

0.70

1.79

2.0

2.2

2.14

2.45

ug/l

0.30

607

Non-small cell lung cancer, including Hilmo

492

0.65

1.78

1.9

2.1

2.09

2.21

ug/l

0.11

399

Benign neoplasm: Choroid

161

1.68

1.78

2.3

2.2

1.42

2.06

ug/l

1.42

140

Other diseases of anus and rectum

110

856

1.28

1.78

2.3

2.1

1.98

2.35

ug/l

0.67

706

Malignant neoplasm of digestive organs

109

1063

0.78

1.77

2.2

2.21

2.35

ug/l

0.17

884

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

177

1.64

1.76

2.3

2.2

2.89

2.33

ug/l

0.40

152

Bacterial pneumonia (organism specified)

107

1234

0.78

1.75

2.0

2.1

2.02

2.28

ug/l

0.55

1021

Open wound of head

184

1432

1.21

1.74

2.3

2.2

2.33

2.24

ug/l

0.11

151

1208

Postmenopausal bleeding

306

1.35

1.70

2.3

2.39

2.64

ug/l

0.36

264

Injuries to the neck

424

1.39

1.68

2.2

1.92

2.26

ug/l

0.54

353

Paralytic ileus and intestinal obstruction

743

1.29

1.68

2.2

2.1

2.50

2.34

ug/l

0.16

612

Chalazion

227

1.55

1.67

2.0

2.3

3.38

2.52

ug/l

0.23

190

Trigger finger

300

1.47

1.67

2.1

2.3

2.73

2.74

ug/l

0.00

245

Abnormal findings in secretions and smears from cervix uteri vagina vulva

554

0.72

1.65

2.3

2.67

2.75

ug/l

0.05

472

Ventral hernia

658

1.31

1.65

2.4

2.2

2.31

2.51

ug/l

0.22

535

Other septicaemia, including avohilmo

150

1151

1.22

1.64

1.9

2.2

2.42

2.28

ug/l

0.18

118

961

Codes for special purposes

164

1342

1.21

1.64

2.2

2.17

2.31

ug/l

0.30

135

1116

Other septicaemia

148

1140

1.23

1.64

1.9

2.2

2.29

ug/l

0.00

116

952

Antihypertensive medication - note that there are other indications

101

408

1.29

1.62

2.2

3.04

2.43

ug/l

0.38

348

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

531

1.34

1.60

2.6

2.3

1.92

2.51

ug/l

1.14

443

Disorders of ocular muscles, binocular movement, accommodation and refraction

121

963

1.25

1.59

2.3

2.2

1.84

2.42

ug/l

1.75

807

Autoimmune diseases related-to ILD

256

1838

1.16

1.58

2.3

2.2

1.91

2.40

ug/l

2.59

211

1536

Superficial injury of lower leg

515

1.34

1.58

2.1

2.2

2.80

2.52

ug/l

0.16

433

severe traumatic brain injury, does not include concussion

655

1.30

1.56

2.1

2.01

2.13

ug/l

0.19

538

Other pulmonary diagnosis

245

1048

1.17

1.55

2.3

2.40

2.54

ug/l

0.16

208

888

Provisional assignment of new diseases of uncertain etiology

163

1343

1.20

1.55

2.2

2.17

2.31

ug/l

0.29

134

1117

Melanoma in situ of other and unspecified parts of face

2.45

1.54

2.0

2.2

1.99

2.02

ug/l

—

Other acute skin changes due to ultraviolet radiation

2.04

1.54

2.1

3.68

2.05

ug/l

0.97

Myocardial infarction, without ST-elevation

118

1317

0.81

1.54

2.2

2.87

2.16

ug/l

0.49

1090

Other and unspecified injuries of thorax

2.44

1.54

2.1

2.5

1.53

2.17

ug/l

—

L02BG Aromatase inhibitors

798

0.74

1.53

2.1

2.3

2.25

2.85

ug/l

1.05

682

Collagenous colitis

208

1.54

1.53

2.3

2.2

2.44

2.37

ug/l

0.05

175

Follicular adenocarcinoma of thyroid gland

3.38

1.53

3.0

2.4

2.10

1.99

ug/l

—

Laparoscopic left hemicolectomy

0.00

1.53

0.0

2.3

—

2.08

—

Conjunctivitis

146

1422

0.83

1.52

2.2

2.77

2.43

ug/l

0.26

122

1191

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

773

1.27

1.52

2.6

2.2

2.76

2.45

ug/l

0.31

657

Viral warts, including avohilmo

399

1.38

1.52

2.7

2.2

1.91

2.25

ug/l

0.55

332

Seropositive rheumatoid arthritis, strict definition

349

1.41

1.50

2.2

2.52

2.38

ug/l

0.12

297

Malignant neoplasm of breast, including Hilmo

628

0.76

1.50

2.2

2.3

2.23

2.88

ug/l

1.26

538

Malignant neoplasm of breast, HER2-negative, including Hilmo

628

0.76

1.50

2.2

2.3

2.23

2.88

ug/l

1.26

538

Explicit Sepsis

168

1279

1.20

1.49

1.9

2.2

2.21

2.33

ug/l

0.20

135

1074

Bacterial meningitis

2.08

1.49

2.2

2.3

1.97

2.22

ug/l

—

Dronedarone medication

1.96

1.49

2.1

1.89

1.81

ug/l

0.07

Bacterial pneumonia, not elsewhere classified

1062

0.79

1.48

2.0

2.2

1.99

2.31

ug/l

0.68

886

Diseases of the ear and mastoid process

322

1412

1.14

1.48

2.2

2.41

2.28

ug/l

0.17

271

1179

Irritable bowel syndrome

565

1.31

1.47

2.3

2.2

1.78

2.46

ug/l

2.11

474

Polymyalgia rheumatica

410

1.37

1.47

2.1

2.2

2.06

2.21

ug/l

0.13

351

Explicit Sepsis, including avohilmo

170

1292

1.19

1.47

1.9

2.2

2.32

ug/l

0.00

137

1085

Excessive earwax

227

1768

1.16

1.46

2.1

2.2

2.06

2.34

ug/l

0.82

178

1486

Polyneuropathies and other disorders of the peripheral nervous system

654

1.29

1.46

2.2

2.1

1.64

2.30

ug/l

2.02

537

137

968

1.22

1.45

2.0

2.2

2.01

2.32

ug/l

0.55

111

799

Dermatophytosis

352

1.40

1.45

2.2

2.04

2.13

ug/l

0.08

295

Alcoholic liver disease

266

0.56

1.44

2.4

2.2

1.60

2.00

ug/l

—

227

Asthma/COPD (KELA code 203)

291

1699

1.14

1.44

2.2

2.22

2.34

ug/l

0.17

249

1415

Cerebrovascular diseases

277

1674

1.15

1.43

2.3

2.2

2.58

2.33

ug/l

0.33

226

1402

Anterior Iridocyclitis

456

1.34

1.42

2.2

1.84

2.43

ug/l

0.91

386

Unspecified mental disorder

773

0.75

1.41

2.1

2.3

2.09

2.41

ug/l

0.34

644

Metabolic disorders

287

1504

1.14

1.40

2.2

2.13

2.42

ug/l

0.79

232

1264

Atopic dermatitis

877

0.79

1.40

2.4

2.2

3.15

2.36

ug/l

0.43

724

Extreme obesity with alveolar hypoventilation

1.86

1.40

1.8

2.2

1.97

1.80

ug/l

—

Disorders of conjunctiva

179

1633

0.85

1.40

2.2

2.72

2.37

ug/l

0.34

150

1365

Pain and other conditions associated with female genital organs and menstrual cycle

191

1.49

1.38

2.2

2.4

4.50

2.83

ug/l

0.43

163

COPD differential diagnosis

242

1046

1.16

1.38

2.3

2.41

2.56

ug/l

0.16

204

883

ILD differential diagnosis

242

1046

1.16

1.38

2.3

2.41

2.56

ug/l

0.16

204

883

Hernia of abdominal wall

156

1309

1.19

1.38

2.2

2.09

2.25

ug/l

0.30

131

1087

Viral and other specified intestinal infections, including avohilmo

358

1.37

1.38

2.2

2.58

2.55

ug/l

0.02

300

Type 2 diabetes, wide definition

269

1479

1.15

1.37

2.1

2.2

2.04

2.41

ug/l

0.87

215

1251

Hypotension

537

1.31

1.37

2.0

2.1

2.16

2.12

ug/l

0.04

440

Disorders of vestibular function (Vertigo)

165

1356

1.19

1.36

2.3

2.2

2.49

2.40

ug/l

0.07

138

1126

Cutaneous abscess, furuncle and carbuncle

555

1.30

1.36

2.2

2.71

2.49

ug/l

0.17

456

Lung diseases due to external agents

365

1.37

1.36

2.2

2.1

2.61

2.14

ug/l

0.31

301

Postmenopausal atrophic vaginitis

304

1.31

1.34

2.2

2.3

2.89

2.62

ug/l

0.19

262

Neurotic, stress-related and somatoform disorders

186

1499

0.85

1.34

2.2

2.54

2.39

ug/l

0.12

150

1258

Vascular disorders of the intestines

191

1.52

1.34

1.6

2.1

1.43

2.06

ug/l

2.16

161

Other disorders of skin and subcutaneous tissue, not elsewhere classified

366

1.37

1.34

2.3

2.2

2.40

2.09

ug/l

0.20

306

Disorders of mineral metabolism

224

1.48

1.33

2.1

1.96

2.25

ug/l

0.38

185

Acute and subacute iridocyclitis

418

1.34

1.33

2.2

1.65

2.32

ug/l

1.63

355

Disturbances of smell and taste

1.79

1.33

2.2

2.3

2.71

2.16

ug/l

0.24

Palmar fascial fibromatosis [Dupuytren]

427

1.34

1.32

2.2

2.1

2.01

2.18

ug/l

0.20

342

Migraine with aura

341

1.38

1.32

2.5

2.3

3.20

2.56

ug/l

0.48

295

Diarrhoea and gastroenteritis of presumed infectious origin

198

1517

1.17

1.32

2.2

2.13

2.28

ug/l

0.34

169

1257

Seborrhoeic keratosis

762

1.25

1.32

2.1

2.2

1.91

2.47

ug/l

1.14

639

Use of pramipexole

620

1.28

1.31

2.0

2.2

2.59

2.44

ug/l

0.13

517

Medicines for HER+ breast cancer

848

0.78

1.31

2.2

2.3

2.39

2.81

ug/l

0.70

728

Benign neoplasm of eye and adnexa

258

1.44

1.31

2.3

2.2

1.34

2.28

ug/l

3.33

216

Diagnoses used for exclusion with ILD

701

1.26

1.30

2.1

2.2

2.34

2.46

ug/l

0.09

575

Uterine polyps

308

1.31

1.30

2.2

2.3

3.40

2.64

ug/l

0.34

266

Bacterial pneumoniae

103

1110

0.81

1.30

2.0

2.2

2.03

2.29

ug/l

0.52

929

Heart failure,strict

213

1283

1.16

1.29

2.1

2.2

2.10

2.35

ug/l

0.60

162

1084

Abdominal and pelvic pain

307

1360

1.13

1.29

2.2

2.54

2.26

ug/l

0.33

255

1142

Headache

188

1243

1.17

1.29

2.4

2.3

2.46

2.32

ug/l

0.13

160

1047

Retinal detachments and breaks

136

1136

1.20

1.28

2.2

2.01

2.30

ug/l

0.58

100

952

Other diseases of blood and blood-forming organs

161

1.56

1.28

2.1

2.2

2.49

1.97

ug/l

0.40

137

Symptoms and signs involving speech and voice

108

884

1.22

1.26

2.5

2.2

2.37

2.43

ug/l

0.07

742

Injuries to the thorax

155

1312

1.18

1.25

2.2

2.65

2.17

ug/l

0.41

129

1089

Anxiety disorders

191

1520

0.86

1.25

2.2

2.58

2.40

ug/l

0.16

153

1275

Other maternal disorders predominantly related to pregnancy

596

0.79

1.25

2.2

2.3

4.09

2.73

ug/l

0.86

511

Diseases of pulp and periapical tissues, including avohilmo

317

1454

1.13

1.24

2.1

2.2

2.28

2.34

ug/l

0.13

269

1219

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

411

0.68

1.24

2.1

2.2

4.86

2.15

ug/l

0.42

339

Type 2 diabetes, strict (exclude DM1)

298

1534

1.13

1.24

2.2

2.22

2.41

ug/l

0.33

238

1297

Cough

129

1004

1.20

1.23

2.3

2.2

2.15

2.39

ug/l

0.52

108

847

Peripheral artery disease

136

1277

0.84

1.23

2.0

2.2

3.03

2.18

ug/l

0.61

103

1069

Excluding asthma or asthma-COPD overlap

240

1048

1.15

1.23

2.3

2.43

2.54

ug/l

0.12

202

888

Malignant neoplasm of digestive organs, including Hilmo

126

1108

0.83

1.22

2.2

2.16

2.35

ug/l

0.29

925

Other and unspecified rosacea

180

1.50

1.20

2.3

2.2

3.77

2.58

ug/l

0.64

152

Intestinal adhesions without obstruction

230

1.44

1.19

2.1

2.2

2.53

2.31

ug/l

0.15

195

Disorders of refraction and accommodation

495

1.29

1.18

2.3

1.80

2.51

ug/l

1.57

421

Type 2 diabetes, definitions combined

296

1529

1.13

1.18

2.2

2.23

2.40

ug/l

0.32

237

1294

Elevated blood glucose level

181

1.50

1.18

1.9

2.3

1.82

2.23

ug/l

0.58

153

Bronchitis, not specified as acute or chronic

181

1.49

1.18

2.4

2.1

2.74

1.93

ug/l

0.58

153

Alzheimer’s disease (Late onset), excluding more controls

315

1.30

1.17

2.1

2.2

1.72

2.10

ug/l

0.69

273

Status post-ami

680

0.79

1.17

2.1

2.2

1.68

2.00

ug/l

1.13

559

Degenerative diseases of the nervous system

113

977

0.83

1.16

2.0

2.1

1.55

2.34

ug/l

3.68

803

Fistulae involving female genital tract

0.00

1.16

0.0

2.2

—

2.12

—

Abrasion of teeth

106

875

1.21

1.16

2.1

2.3

2.20

2.46

ug/l

0.34

725

Contusion of toe(s) without damage to nail

0.00

1.16

0.0

2.2

—

1.73

—

Angina pectoris

215

1244

1.15

1.16

2.3

2.2

2.84

2.33

ug/l

0.57

177

1041

Abnormal findings on examination of blood, without diagnosis

171

1331

1.16

2.1

2.2

1.91

2.20

ug/l

1.04

136

1108

Beningn neoplasm: Meninges, unspecified

0.00

1.15

0.0

2.2

—

2.12

—

Bronchitis

274

1849

0.89

1.15

2.2

2.28

2.34

ug/l

0.13

235

1537

Gout, unspecified

705

1.24

1.14

2.4

2.1

2.07

2.00

ug/l

0.11

570

Superficial injury of head

579

1.26

1.14

2.1

2.2

2.36

2.53

ug/l

0.15

492

Other reaction to severe stress, and adjustment disorders

535

1.27

1.13

2.4

2.3

3.46

2.39

ug/l

0.43

458

GI-bleeding

121

1014

1.19

1.13

2.2

2.1

2.60

2.22

ug/l

0.40

103

828

Injuries to unspecified part of trunk, limb or body region

216

1.44

1.13

2.1

2.2

2.34

1.94

ug/l

0.36

183

Asthma (only as main-diagnosis)

213

1038

1.15

1.13

2.2

2.3

2.24

2.56

ug/l

0.35

183

878

Algoneurodystrophy

2.01

1.12

2.0

2.3

1.26

2.56

ug/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

107

998

0.83

1.11

2.2

2.32

2.44

ug/l

0.15

830

Benign lipomatous neoplasm

762

1.22

1.11

2.2

2.08

2.48

ug/l

0.74

633

Cellulitis

520

1.27

1.11

2.3

2.2

1.80

2.51

ug/l

1.52

435

Colorectal cancer, including Hilmo

888

0.81

1.10

2.2

2.19

2.36

ug/l

0.25

737

Other noninfective gastroenteritis and colitis

565

1.26

1.09

2.1

2.2

2.13

2.52

ug/l

0.50

477

Lumbosacral root disorders, not elsewhere classified

2.40

1.09

1.8

2.3

2.32

2.04

ug/l

—

Anxiety (asthma-related co-morbidities)

908

0.83

1.08

2.1

2.3

1.88

2.40

ug/l

1.66

762

Exclusions for E4_PCOS_BROAD

320

1.34

1.08

2.2

2.3

2.59

2.60

ug/l

0.00

267

Other fall from one level to another

460

1.28

1.07

2.3

2.2

1.87

2.33

ug/l

0.90

382

Other or unspecified ileus, impaction or obstruction

549

1.26

1.07

2.2

2.1

2.39

2.35

ug/l

0.03

453

Operations 2 for CAVS

122

991

1.19

1.07

2.1

2.07

2.15

ug/l

0.14

102

813

Calcific aortic valvular stenosis, diagnosis (helper)

122

991

1.19

1.07

2.1

2.07

2.15

ug/l

0.14

102

813

Other embolism and thrombosis

304

1.35

1.06

2.2

4.67

2.08

ug/l

0.65

256

Phlebitis and thrombophlebitis (not including DVT)

541

1.26

1.06

2.0

2.2

2.40

2.41

ug/l

0.01

454

Calcific aortic valvular stenosis, operated

122

992

1.18

1.06

2.1

2.07

2.15

ug/l

0.14

102

814

Calcific aortic valvular stenosis

122

992

1.18

1.06

2.1

2.07

2.15

ug/l

0.14

102

814

Alzheimer’s disease (Atypical or mixed)

310

0.67

1.06

1.8

2.1

2.14

2.08

ug/l

0.05

256

Malignant neoplasm of breast

628

0.81

1.06

2.2

2.3

2.18

2.88

ug/l

1.47

538

Malignant neoplasm of breast, HER2-negative

628

0.81

1.06

2.2

2.3

2.18

2.88

ug/l

1.47

538

Other diseases of the digestive system

120

1014

1.18

1.05

2.2

2.1

2.60

2.22

ug/l

0.39

100

825

Colorectal cancer

834

0.80

1.05

2.2

2.23

2.39

ug/l

0.22

692

Gout, idiopatic and unspecified

104

868

1.20

1.05

2.4

2.1

2.11

2.02

ug/l

0.13

700

Asthma (only as main-diagnosis), excluding more controls

198

956

1.15

1.04

2.2

2.3

2.29

2.57

ug/l

0.28

169

817

ILD, hospital admissions

454

1.28

1.04

1.9

2.1

1.63

2.20

ug/l

1.86

371

Calcific aortic valvular stenosis, including rheumatic fever

122

993

1.18

1.04

2.1

2.07

2.15

ug/l

0.14

102

814

Pain associated with micturition

280

1.36

1.03

2.3

2.2

3.92

2.16

ug/l

0.47

245

Glaucoma, exfoliation

306

1.34

1.03

2.4

2.2

3.27

2.06

ug/l

0.85

258

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

563

1.25

1.03

2.4

2.3

2.42

2.47

ug/l

0.04

477

Fibroblastic disorders

589

1.24

1.02

2.2

1.98

2.34

ug/l

0.62

479

Other CVD

616

1.24

1.02

2.1

2.15

2.11

ug/l

0.04

504

Other degenerative diseases of the nervous system

559

1.21

1.02

2.1

2.2

1.41

2.36

ug/l

5.02

483

Diseases of external ear

113

953

1.19

1.02

2.3

2.2

2.51

2.39

ug/l

0.08

789

Sequelae of cerebrovascular disease

108

1094

0.84

1.01

2.2

2.1

2.16

2.26

ug/l

0.16

911

Neoplasms

172

782

1.15

1.01

2.3

2.31

2.37

ug/l

0.06

140

662

Medical abortion

143

662

1.17

1.00

2.6

2.2

2.77

2.73

ug/l

0.02

118

571

Diabetic nephropathy

387

0.71

1.00

1.8

2.2

3.45

1.99

ug/l

0.43

308

Iridocyclitis

528

1.25

1.00

2.2

1.95

2.45

ug/l

0.84

442

Type 2 diabetes

294

1529

1.11

1.00

2.2

2.15

2.40

ug/l

0.50

236

1294

Aplastic and other anaemias

177

1416

1.14

1.00

2.0

2.2

2.44

2.26

ug/l

0.31

147

1177

Ischaemic heart disease, wide definition

269

1482

1.12

0.99

2.3

2.2

2.83

2.32

ug/l

0.72

225

1239

Intestinal infectious diseases, including avohilmo, including avohilmo

352

1779

1.10

0.98

2.2

2.19

2.35

ug/l

0.40

293

1487

Malignant neoplasm of gum, including Hilmo

2.19

0.98

2.2

2.1

1.28

2.45

ug/l

—

Ulcer of lower limb, not elsewhere classified

423

1.28

0.98

2.2

3.34

2.09

ug/l

0.65

346

Benign paroxysmal vertigo

820

1.20

0.98

2.4

2.2

2.10

2.42

ug/l

0.62

686

Tinnitus

620

1.23

0.97

2.4

2.2

1.88

2.44

ug/l

0.98

509

Peripheral arterial reconstruction

538

0.76

0.97

2.1

3.07

2.00

ug/l

0.46

434

Meningitis

1.67

0.97

2.3

1.86

1.98

ug/l

—

Persons encountering health services for specific procedures, not carried out

140

1.50

0.97

2.0

2.2

2.21

2.01

ug/l

0.11

121

Other specified/unspecified systemic involvement of connective tissue

108

1.58

0.96

1.9

2.2

3.48

2.43

ug/l

0.44

Visual disturbances and blindness

166

1450

1.14

0.96

2.1

2.2

2.72

2.31

ug/l

0.36

136

1204

Impacted cerumen

319

1.32

0.96

2.3

2.2

1.63

2.14

ug/l

1.34

266

Speech disturbances, not elsewhere classified

216

1.39

0.95

2.3

2.2

2.84

2.09

ug/l

0.53

184

Diseases of the myoneural junction and muscle

302

1.33

0.95

2.0

2.3

1.89

2.00

ug/l

0.14

254

Other interstitial pulmonary diseases

461

1.26

0.94

1.9

2.1

1.63

2.22

ug/l

1.96

377

Type 2 diabetes, definitions combined, including avohilmo

290

1512

1.11

0.94

2.2

2.16

2.41

ug/l

0.50

232

1278

Caries of enamel

277

1632

1.11

0.93

2.4

2.2

2.68

2.30

ug/l

0.93

232

1368

Oral lichen planus, including avohilmo , including avohilmo

158

1.46

0.93

2.6

2.2

2.81

2.42

ug/l

0.21

136

Alzheimer disease

104

877

0.85

0.92

2.0

2.1

1.58

2.36

ug/l

3.22

725

Interstitial lung disease

463

1.25

0.92

1.9

2.1

1.63

2.20

ug/l

1.90

380

Interstitial lung disease endpoints

463

1.25

0.92

1.9

2.1

1.63

2.20

ug/l

1.90

380

L02BA Anti-estrogens

350

0.71

0.91

2.3

2.2

2.45

2.87

ug/l

0.30

303

Other respiratory diseases principally affecting the interstitium

553

1.23

0.91

2.0

2.1

1.50

2.17

ug/l

2.96

456

Benign neoplasm: Skin of eyelid, including canthus

419

1.27

0.91

2.1

2.2

2.18

2.48

ug/l

0.20

353

Presbycusis

458

1.25

0.90

2.2

2.1

2.36

2.11

ug/l

0.29

383

Implicit bacterial Sepsis, including avohilmo

178

1306

1.13

0.90

2.0

2.2

2.21

2.32

ug/l

0.15

139

1097

Localized swelling, mass and lump of skin and subcutaneous tissue

801

1.19

0.89

2.1

2.2

2.88

2.32

ug/l

0.28

662

Voice disturbances

655

1.21

0.89

2.7

2.2

2.00

2.55

ug/l

0.86

549

Triptan medication for migraine, single purchase ok

134

1046

0.87

0.89

2.5

2.3

2.39

2.55

ug/l

0.33

116

875

Migraine, single triptan purchase ok & required. ICD-code if available is included

134

1046

0.87

0.89

2.5

2.3

2.39

2.55

ug/l

0.33

116

875

Other disorders of kidney and ureter

341

1.29

0.88

2.6

2.2

2.35

2.26

ug/l

0.08

285

Pre-eclampsia or eclampsia

271

1.33

0.88

2.3

3.02

3.01

ug/l

0.01

232

Certain disorders involving the immune mechanism

412

1.26

0.88

2.3

3.13

2.42

ug/l

0.43

345

Nontraumatic intracranial haemmorrhage

607

0.79

0.88

2.1

1.80

2.14

ug/l

0.56

504

Focal brain injury

127

1.50

0.88

1.8

2.1

1.73

1.90

ug/l

0.18

113

Endovascular or surgical operations to intracerebral aneurysms

127

0.55

0.88

2.4

2.2

2.06

2.10

ug/l

—

114

Viral haemorrhagic fevers, not elsewhere classified/unspecified

169

0.59

0.88

2.4

2.3

0.96

2.04

ug/l

—

142

Fracture of rib(s), sternum and thoracic spine

106

904

1.17

0.88

2.3

2.2

2.56

2.21

ug/l

0.19

740

Abnormalities of heart beat

108

894

1.17

0.88

2.4

2.2

2.03

2.39

ug/l

0.84

748

Subjective visual disturbances

620

1.21

0.87

2.1

2.2

2.59

2.44

ug/l

0.13

521

Nonsuppurative otitis media, including avohilmo

428

0.77

0.87

2.4

2.2

2.35

2.54

ug/l

0.15

361

Degenerative macular diseases

360

1.28

0.86

2.0

2.2

1.70

2.08

ug/l

0.61

305

Intestinal stricture

108

924

1.17

0.86

2.2

2.47

2.38

ug/l

0.09

766

All chronic kidney diseases

186

1316

1.13

0.86

2.2

2.23

ug/l

0.01

144

1117

Transient ischemic attack

203

1443

1.12

0.86

2.3

2.2

2.39

2.31

ug/l

0.07

173

1200

Diseases of the respiratory system

197

876

1.13

0.85

2.3

2.2

2.51

ug/l

0.01

166

738

Acne

1.81

0.85

2.4

2.3

4.65

2.64

ug/l

—

Allergic conjunctivitis

1105

0.85

2.2

2.3

2.99

2.55

ug/l

0.22

938

All anxiety disorders

901

0.85

2.1

2.3

1.88

2.34

ug/l

1.36

755

Abnormal involuntary movements

326

1.29

0.84

2.6

2.2

3.92

2.06

ug/l

0.53

277

Specific personality disorders

321

0.72

0.84

2.0

2.2

5.71

2.51

ug/l

0.36

275

Open wound of forearm

196

1.38

0.84

2.3

2.2

1.82

1.95

ug/l

0.12

165

Disturbances of skin sensation

524

1.22

0.83

2.5

2.2

2.37

2.40

ug/l

0.02

432

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1055

0.85

0.82

2.3

3.06

2.55

ug/l

0.25

894

Endometriosis ASRM stages 3,4

381

1.26

0.82

2.2

2.02

2.92

ug/l

1.31

325

Symptoms and signs involving the digestive system and abdomen

298

1360

1.10

0.81

2.2

2.63

2.26

ug/l

0.45

248

1142

Acute upper respiratory infections

274

1803

0.91

0.81

2.2

2.25

2.36

ug/l

0.24

231

1499

Other benign neoplasms of skin

121

1052

1.15

0.80

2.2

2.15

2.39

ug/l

0.39

879

Colorectal adenocarcinoma

721

0.82

0.80

2.2

2.27

2.17

ug/l

0.11

598

Follow-up examination after treatment for malignant neoplasms

259

1.31

0.79

2.0

2.2

1.97

2.58

ug/l

0.59

222

Drug-induced adrenocortical insufficiency

1.82

0.79

2.0

2.3

2.08

2.24

ug/l

—

Convulsions, not elsewhere classified

491

0.78

2.0

2.2

1.70

2.26

ug/l

1.11

403

Burn and corrosion of wrist and hand

1.67

0.78

2.9

2.2

3.69

1.71

ug/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

415

1.24

0.78

2.3

2.1

1.95

2.16

ug/l

0.23

347

Rosacea

251

1.32

0.78

2.3

2.2

3.40

2.73

ug/l

0.36

212

Osteomyelitis

148

1.42

0.77

2.1

2.2

1.81

2.01

ug/l

0.18

121

Diabetes, varying definitions

289

1530

1.09

0.77

2.2

2.19

2.40

ug/l

0.40

232

1295

Diabetic retinopathy, excluding more controls

339

1.21

0.77

2.2

2.68

2.02

ug/l

0.43

278

Perichondritis of external ear

1.77

0.76

3.2

2.1

3.02

2.52

ug/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.70

0.76

2.1

3.52

2.03

ug/l

—

Chronic mastoiditis

1.70

0.76

2.1

6.74

2.23

ug/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

788

1.17

0.75

2.2

2.25

2.41

ug/l

0.11

665

Glucagon-like peptide-1 (GLP-1) analogues

788

1.17

0.75

2.2

2.25

2.41

ug/l

0.11

665

Coagulation defects, purpura and other haemorrhagic conditions

449

1.23

0.75

2.1

2.2

2.25

2.35

ug/l

0.09

376

Medial epicondylitis

1.67

0.74

1.4

2.5

1.47

2.80

ug/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

432

1.23

0.74

1.8

2.2

1.86

2.43

ug/l

1.02

362

Benign neoplasm: Descending colon

184

1.36

0.73

2.5

2.3

1.74

2.06

ug/l

0.45

155

Cervicocranial syndrome

184

1.36

0.73

2.3

1.62

3.07

ug/l

1.56

153

138

1391

0.88

0.73

2.3

2.2

2.02

2.20

ug/l

0.46

114

1157

Right hemicolectomy

132

0.60

0.73

2.0

2.3

2.54

2.01

ug/l

—

112

Viral pneumonia

316

1.27

0.73

2.1

2.2

2.00

2.15

ug/l

0.16

262

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

193

1.35

0.73

2.1

2.3

1.43

2.10

ug/l

1.59

165

Anxiety disorders, excluding more controls

190

1347

0.90

0.73

2.2

2.59

2.42

ug/l

0.14

152

1131

Diabetes mellitus

289

1530

1.09

0.73

2.2

2.19

2.40

ug/l

0.40

232

1295

Other obstructed labour

100

1.50

0.72

2.9

2.2

2.85

3.53

ug/l

0.23

Familial hypercholesterolemia

506

1.21

0.72

2.0

2.1

1.86

2.18

ug/l

0.70

418

Divergent concomitant strabismus

125

1.44

0.72

2.0

2.2

2.29

2.69

ug/l

0.12

107

Renal failure

183

1402

1.11

0.72

2.1

2.2

2.23

2.27

ug/l

0.06

143

1176

Myocardial infarction, unclassifiable

605

0.83

0.72

2.0

2.1

2.00

2.03

ug/l

0.03

492

Visual disturbances

150

1336

1.12

0.72

2.1

2.2

2.82

2.30

ug/l

0.44

124

1108

Functional dyspepsia

617

1.18

0.71

2.1

2.2

2.17

2.47

ug/l

0.37

515

Other symptoms and signs involving the digestive system and abdomen

398

1.23

0.71

2.4

2.2

4.78

2.45

ug/l

1.28

338

Personal history of other diseases and conditions

1.52

0.70

2.2

1.30

2.99

ug/l

—

Any dementia

138

1075

0.89

0.70

2.0

2.1

1.71

2.33

ug/l

2.70

112

893

Other and unspecified vasculitis limited to skin

1.56

0.70

2.9

2.2

2.33

2.19

ug/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

684

1.17

0.69

2.4

2.2

1.64

2.53

ug/l

3.05

577

Malignant neoplasm of colon, including Hilmo

626

0.83

0.68

2.1

2.2

2.04

2.28

ug/l

0.35

517

Other and unspecified anaemias

161

1356

1.11

0.68

2.1

2.2

2.38

2.26

ug/l

0.19

135

1131

Heart failure, strict

236

1498

1.09

0.68

2.1

2.2

2.04

2.32

ug/l

0.78

181

1258

Other symptoms and signs involving cognitive functions and awareness

168

1339

1.11

0.68

2.4

2.2

1.97

2.39

ug/l

1.46

141

1101

Implicit viral Sepsis, including avohilmo

105

917

1.14

0.67

2.1

1.76

2.37

ug/l

1.99

759

Simple and mucopurulent chronic bronchitis

0.55

0.67

1.8

2.2

1.52

1.94

ug/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

227

1805

1.09

0.67

2.2

2.38

2.33

ug/l

0.04

180

1518

Early onset COPD

638

0.83

0.67

2.2

3.37

2.30

ug/l

0.36

523

Viral and other specified intestinal infections

243

1.29

0.66

2.1

2.97

2.39

ug/l

0.21

207

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.53

0.66

2.6

2.2

1.12

1.96

ug/l

—

Mixed conductive and sensorineural hearing loss

351

0.77

0.66

2.8

2.2

2.15

2.19

ug/l

0.04

300

Other anaemias

162

1364

1.11

0.66

2.1

2.2

2.42

2.25

ug/l

0.28

136

1134

FESS (DNB20)

260

0.73

0.66

2.0

2.2

1.81

2.40

ug/l

0.59

221

Follow-up care involving plastic surgery

1.54

0.65

1.9

2.2

1.10

2.47

ug/l

—

Abnormal spermatozoa

403

1.22

0.65

2.0

2.2

2.05

2.01

ug/l

0.05

327

Disorders of skin appendages

117

1029

1.13

0.65

2.3

2.2

2.78

2.34

ug/l

0.64

103

852

Malignant neoplasm of head and neck

224

1.30

0.64

1.9

2.2

1.46

1.83

ug/l

0.89

187

Gout due to impairment of renal function

1.73

0.64

3.4

2.3

1.84

1.89

ug/l

—

Malignant melanoma

505

1.19

0.63

2.1

2.2

1.85

2.25

ug/l

0.81

414

Other headache syndromes

101

883

1.14

0.63

2.4

2.2

2.38

2.49

ug/l

0.13

755

Glomerulonephritis

207

1.31

0.63

2.8

2.2

2.46

2.11

ug/l

0.13

177

Diseases of the digestive system

151

1349

1.11

0.62

2.3

2.1

2.55

2.26

ug/l

0.36

129

1115

Benign neoplasm: Colon, unspecified

822

1.14

0.62

2.3

2.2

2.35

2.33

ug/l

0.02

678

Pneumonitis due to solids and liquids

199

1.31

0.62

2.0

2.2

3.29

1.96

ug/l

0.51

164

Benign thyroid growths and nodules

100

816

1.14

0.62

2.3

3.46

2.49

ug/l

1.02

697

Dentofacial anomalies [including malocclusion]

158

1115

1.11

0.61

2.3

2.62

2.51

ug/l

0.09

132

930

Stroke, excluding SAH

224

1483

1.09

0.61

2.2

2.10

2.33

ug/l

0.67

183

1234

Agranulocytosis

256

0.74

0.61

2.2

2.81

2.60

ug/l

0.12

217

Umbilical hernia

684

1.16

0.60

2.1

2.2

2.01

2.21

ug/l

0.22

550

malignant neoplasm of male genital organs

114

607

1.13

0.60

2.1

2.2

2.44

1.86

ug/l

0.66

498

Serous carcinoma of ovary

0.00

0.60

0.0

2.5

—

2.59

—

Encephalopathy

0.00

0.60

0.0

2.2

—

1.85

—

Diabetic nephropathy, excluding more controls

291

0.78

0.60

1.8

2.2

3.45

1.93

ug/l

0.45

238

Squamous cell neoplasms and carcinomas of the skin

325

1.23

0.60

2.2

2.1

2.08

1.86

ug/l

0.22

270

Pre-eclampsia or poor fetal growth

306

1.24

0.60

2.2

2.3

2.88

2.94

ug/l

0.03

265

Alcohol dependence

694

0.85

0.59

2.3

2.2

1.84

2.20

ug/l

0.77

576

Benign neoplasm: Bladder

0.00

0.59

0.0

2.2

—

1.71

—

Pedestrian injured in other and unspecified transport accidents

0.00

0.59

0.0

2.6

—

2.52

—

Endometriosis of pelvic peritoneum

190

1.29

0.59

2.3

2.4

5.09

2.85

ug/l

0.31

166

Endocrine, nutritional and metabolic diseases

189

868

1.10

0.59

2.3

2.2

2.45

2.30

ug/l

0.19

159

744

COPD-related respiratory insufficiency

355

0.79

0.59

1.8

2.2

1.77

2.05

ug/l

0.20

293

Alzheimer’s disease (Atypical or mixed), excluding more controls

199

0.75

0.58

1.8

2.2

1.83

2.10

ug/l

0.41

172

Retinal breaks without detachment

464

1.19

0.58

2.5

2.2

1.96

2.52

ug/l

0.80

384

Crohn's disease of small intestine

113

0.62

0.58

3.6

2.3

1.61

2.35

ug/l

—

101

Other and unspecified dermatitis

154

1396

1.10

0.58

2.3

2.2

2.46

2.33

ug/l

0.17

130

1160

Ovarian dysfunction

1.72

0.57

2.0

2.3

1.88

2.67

ug/l

—

Fourth [trochlear] nerve palsy

1.49

0.57

2.0

2.2

1.63

2.30

ug/l

—

Other disorders of amniotic fluid and membranes

1.49

0.57

2.6

2.1

1.63

2.34

ug/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

309

0.78

0.57

2.3

2.1

2.77

1.84

ug/l

0.79

255

Inflammatory diseases of the central nervous system

158

1.33

0.57

2.1

2.2

1.71

2.17

ug/l

0.58

137

Peripheral artery operations in Hilmo

353

0.79

0.57

1.7

2.2

2.41

1.91

ug/l

0.61

292

Other coagulation defects

132

1.37

0.57

2.1

2.2

2.87

2.07

ug/l

0.36

112

Viral infections characterized by skin and mucous membrane lesions

112

998

1.12

0.57

2.3

2.2

2.52

2.32

ug/l

0.18

836

Malignant neoplasm of head and neck, including Hilmo

292

1.23

0.56

2.0

2.2

1.40

2.05

ug/l

2.23

240

Biguanides

291

1635

1.07

0.56

2.1

2.2

2.00

2.41

ug/l

1.13

230

1383

Malignant neoplasm of rectum, including Hilmo

385

0.80

0.55

2.4

2.1

2.37

2.24

ug/l

0.09

317

Cardiomyopathy

494

0.83

0.55

2.2

2.0

1.79

2.13

ug/l

0.50

401

Disorders of other endocrine glands

111

976

1.12

0.55

2.2

2.82

2.46

ug/l

0.27

813

Asthma, hospital admissions 3, pneumonia

112

998

1.12

0.55

2.1

2.64

2.40

ug/l

0.13

828

Asthma-related pneumonia or sepsis

112

998

1.12

0.55

2.1

2.64

2.40

ug/l

0.13

828

Other disorders of eyelid

160

1376

1.10

0.54

2.0

2.2

2.23

2.35

ug/l

0.20

140

1142

Asthma, hospital admissions , main diagnosis only

226

1818

1.08

0.54

2.2

2.27

2.36

ug/l

0.09

194

1516

Disorders of sclera, cornea, iris and ciliary body

155

1412

1.10

0.54

2.2

2.40

2.27

ug/l

0.09

127

1171

Gout, strict definition

617

1.15

0.54

2.6

2.1

2.02

2.01

ug/l

0.01

498

Infections with a predominantly sexual mode of transmission

366

1.20

0.54

2.3

2.2

3.88

2.51

ug/l

0.37

307

Other gastritis (incl. Duodenitis)

636

1.15

0.53

2.3

2.2

2.09

2.45

ug/l

0.52

527

All-cause Heart Failure

232

1494

1.08

0.53

2.1

2.2

2.06

2.32

ug/l

0.70

178

1255

Dipeptidyl peptidase 4 (DPP-4) inhibitors

205

1482

1.08

0.53

2.1

2.2

1.69

2.39

ug/l

4.82

157

1248

Ethmoidectomy

272

0.77

0.53

1.9

2.2

1.79

2.37

ug/l

0.66

229

Malignant neoplasm of breast, ER-positive, including Hilmo

606

0.87

0.53

2.2

2.3

2.39

2.89

ug/l

0.78

518

Dermatitis

189

1701

1.09

0.53

2.3

2.2

2.43

2.32

ug/l

0.17

158

1424

Retention of urine

128

934

1.11

0.52

2.2

2.73

2.04

ug/l

0.52

104

777

Injuries to the elbow and forearm

194

1531

1.09

0.52

2.4

2.2

2.62

2.42

ug/l

0.34

164

1277

Malignant neoplasm of rectum

315

0.79

0.52

2.2

2.1

2.43

1.92

ug/l

0.41

259

Chronic gastritis

817

1.13

0.51

2.0

2.1

3.94

2.42

ug/l

0.84

671

Malignant neoplasm of breast, HER-positive

605

0.87

0.51

2.2

2.3

2.39

2.88

ug/l

0.75

517

Other otitis externa (chronic)

135

0.67

0.51

3.1

2.3

1.42

2.42

ug/l

—

119

Vasculitis limited to skin, not elsewhere classified

1.41

0.51

2.9

2.2

2.33

2.19

ug/l

—

Secondary hypertension

150

1.31

0.51

2.6

2.1

3.45

2.34

ug/l

0.36

130

Multiple delivery

1.41

0.50

2.5

2.2

2.71

1.99

ug/l

0.57

Other disorders of penis

206

1.26

0.50

2.5

2.1

1.94

1.76

ug/l

0.14

170

Coronary atherosclerosis

224

1310

1.08

0.50

2.2

2.97

2.35

ug/l

0.75

184

1095

Other and unspecified nail disorders

1.47

0.50

1.8

2.3

1.95

2.18

ug/l

—

In situ neoplasms

129

1171

1.10

0.50

2.1

2.2

1.90

2.41

ug/l

1.28

111

968

Myocardial infarction, strict

140

1087

0.91

0.50

2.1

2.2

2.91

2.28

ug/l

0.51

115

907

DVT of lower extremities

491

1.16

0.50

2.1

2.2

2.99

2.33

ug/l

0.50

409

Any dementia, excluding more controls

133

1004

0.91

0.49

2.0

2.2

1.72

2.18

ug/l

1.82

108

842

Other blood glucose lowering drugs, excl. Insulins

482

1.16

0.49

2.3

2.2

1.64

2.33

ug/l

1.95

397

Malignant neoplasm of prostate

113

601

1.11

0.49

2.0

2.2

2.44

1.87

ug/l

0.63

493

ILD, hospital admissions 1, main diag only

408

1.18

0.49

1.9

2.2

1.69

2.12

ug/l

1.04

340

Other disorders of breast

234

1.24

0.49

2.2

2.3

3.00

3.11

ug/l

0.05

203

L01XE Protein kinase inhibitors

144

0.69

0.49

2.4

2.2

2.03

1.88

ug/l

—

123

Asthma-related pneumonia

111

998

1.11

0.48

2.1

2.65

2.40

ug/l

0.13

828

Parkinson's disease, including avohilmo

497

0.84

0.48

2.1

2.2

2.20

2.07

ug/l

0.10

409

Nontoxic multinodular goitre

511

1.16

0.48

2.6

2.3

3.42

2.46

ug/l

0.62

441

Nausea and vomiting

681

1.13

0.48

2.3

2.2

2.21

2.31

ug/l

0.11

564

Substance use, excluding alcohol

335

1.19

0.48

2.4

2.2

2.12

2.30

ug/l

0.14

287

Wet age-related macular degeneration

565

1.14

0.48

2.1

2.43

2.29

ug/l

0.11

470

Examination and encounter for administrative purposes

235

1.24

0.48

2.6

2.3

1.88

2.38

ug/l

0.78

199

Asthma, hospital admission 2, infections

161

1443

1.09

0.48

2.2

2.46

2.37

ug/l

0.06

131

1190

Asthma-related infections

161

1443

1.09

0.48

2.2

2.46

2.37

ug/l

0.06

131

1190

Endometriosis ASRM stages 1,2

226

1.24

0.47

2.3

2.2

5.09

2.89

ug/l

0.30

191

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

322

0.81

0.47

2.2

2.1

2.77

1.89

ug/l

0.73

264

Hydronephrosis

300

0.80

0.47

2.2

2.1

2.06

2.24

ug/l

0.11

251

Nontoxic goitre/thyroid nodule

767

1.12

0.47

2.4

2.2

3.26

2.49

ug/l

0.70

647

103

921

1.11

0.46

2.3

2.2

2.04

2.43

ug/l

0.82

765

Irregular menses

497

1.13

0.46

2.1

2.3

3.56

2.73

ug/l

0.37

429

Bipolar affective disorders

277

0.79

0.46

1.9

2.2

6.41

2.54

ug/l

0.49

237

Stroke, including SAH

227

1519

1.07

0.46

2.2

2.12

2.33

ug/l

0.58

187

1267

Other congenital malformations, including avohilmo

191

1.26

0.46

2.5

2.2

2.74

2.53

ug/l

0.09

165

Other strabismus

391

1.17

0.46

2.1

2.2

2.01

2.33

ug/l

0.28

331

Polypectomy (DHB20)

153

0.72

0.45

2.2

2.3

2.32

2.00

ug/l

0.22

130

Abnormalities of forces of labour

1.43

0.45

2.0

2.3

4.20

3.56

ug/l

0.12

Adjustment and management of implanted device

552

1.14

0.45

2.1

2.2

2.12

1.97

ug/l

0.28

462

Malignant neoplasm of larynx, including Hilmo

1.40

0.45

2.4

2.3

0.90

1.79

ug/l

—

Cystitis

245

1363

1.07

0.45

2.2

2.15

2.37

ug/l

0.44

195

1141

Benign neoplasm of major salivary glands

242

0.78

0.44

1.8

2.2

1.52

2.27

ug/l

1.08

205

Bacterial Sepsis

172

1316

1.08

0.44

2.0

2.2

2.16

2.32

ug/l

0.25

135

1105

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

163

0.73

0.44

2.0

2.1

1.98

1.93

ug/l

0.04

136

Inflammatory diseases of female pelvic organs

130

813

1.09

0.43

2.1

2.3

2.48

2.82

ug/l

0.47

102

704

Acute renal failure

724

1.12

0.43

2.0

2.1

2.14

2.26

ug/l

0.11

598

Disorders of tooth development and eruption

208

1.21

0.43

2.3

2.4

1.92

2.75

ug/l

0.69

175

Disorders of acoustic nerve

1.43

0.42

2.3

2.2

2.49

2.02

ug/l

—

Fracture of skull and facial bones

471

1.15

0.42

2.3

2.2

2.07

2.49

ug/l

0.54

397

Glomerular diseases

434

1.15

0.42

2.4

2.2

2.32

2.19

ug/l

0.09

358

Budesonide

267

1.20

0.42

1.9

2.2

1.46

2.52

ug/l

1.69

226

Unspecified kidney failure

294

0.82

0.41

2.0

2.1

2.02

2.11

ug/l

0.08

243

Hidradenitis suppurativa

1.52

0.41

2.0

2.3

1.60

1.91

ug/l

—

Mental and behavioural disorders due to cannabinoids

0.00

0.41

0.0

2.0

—

2.34

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.00

0.41

0.0

2.3

—

2.85

—

Psoriasis

680

1.12

0.41

2.3

2.2

2.04

2.41

ug/l

0.65

565

Strabismus

518

1.14

0.41

2.1

2.2

1.87

2.53

ug/l

0.89

436

Oral leukoplakia, including avohilmo

1.36

0.41

2.7

2.3

3.41

2.19

ug/l

—

Benign neoplasm: Cranial nerves

1.36

0.41

2.3

2.2

2.49

2.23

ug/l

—

Melanocytic naevi, other sites/unspecified

161

0.74

0.41

2.5

2.3

2.68

2.13

ug/l

0.31

138

Diseases of salivary glands

766

1.11

0.40

2.4

2.2

3.69

2.41

ug/l

0.61

640

Appendectomy

133

1372

0.92

0.40

2.2

2.76

2.32

ug/l

0.32

108

1142

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

293

0.82

0.40

2.5

2.2

2.98

2.16

ug/l

0.31

243

Amyloidosis, other/unspecified

1.34

0.40

2.8

2.2

2.18

2.01

ug/l

—

Other dialysis

1.34

0.40

1.5

2.3

2.29

1.78

ug/l

—

Parkinson's disease

476

0.86

0.40

2.1

2.2

2.13

2.09

ug/l

0.03

392

Other hearing loss

100

881

1.10

0.40

2.2

2.1

2.14

2.24

ug/l

0.13

728

Benign neoplasm: Rectum, anus and anal canal

635

0.88

0.40

2.1

2.2

2.18

2.32

ug/l

0.12

524

Bell's palsy

232

1.21

0.39

2.2

1.86

2.31

ug/l

0.47

201

Heart failure and coronary heart disease

160

1040

1.08

0.39

2.0

2.2

1.90

2.17

ug/l

0.97

126

862

Injury of urinary and pelvic organs

1.43

0.39

2.4

2.3

2.36

1.98

ug/l

—

Vascular syndromes of brain in cerebrovascular disorders

106

0.66

0.39

2.3

2.23

2.07

ug/l

—

Malignant melanoma, including Hilmo

560

1.13

0.38

2.1

2.2

1.85

2.34

ug/l

1.03

461

Injuries to the wrist and hand

288

1808

1.06

0.38

2.2

2.17

2.34

ug/l

0.42

239

1514

Primary open-angle glaucoma

119

1053

1.09

0.38

2.2

2.1

2.45

2.31

ug/l

0.16

878

Poisoning by medicine

307

1.17

0.38

2.4

2.2

2.14

2.48

ug/l

0.29

260

Chronic kidney disease

119

1054

1.09

0.38

2.2

2.1

2.28

2.21

ug/l

0.08

873

Other (not insulin) diabetes medications

294

1636

1.05

0.37

2.2

2.07

2.42

ug/l

0.90

233

1382

Pregnancy with abortive outcome

138

664

1.08

0.37

2.5

2.2

3.27

2.74

ug/l

0.41

117

572

Necrosis of pulp, including avohilmo

140

1283

1.08

0.37

2.2

2.19

2.33

ug/l

0.22

119

1061

Lichen planus

344

0.84

0.37

2.4

2.3

1.80

2.26

ug/l

0.44

295

Migraine

673

1.10

0.37

2.6

2.3

2.80

2.49

ug/l

0.39

577

Antepartum haemorrhage, not elsewhere classified

1.35

0.37

2.0

2.2

7.22

2.49

ug/l

—

Disorder of lipoprotein metabolism, unspecified

429

0.86

0.36

2.5

2.1

2.57

2.25

ug/l

0.22

356

Amyloidosis

1.29

0.36

2.7

2.2

2.10

2.01

ug/l

—

Delivery, wide proxy

337

1.12

0.36

2.5

2.1

2.12

2.31

ug/l

0.26

281

Faecal incontinence

253

1.19

0.36

2.1

2.3

2.40

2.66

ug/l

0.15

215

Other disorders of prostate

1.36

0.36

2.5

2.1

1.20

1.62

ug/l

0.97

malignant neoplasm of male genital organs, including Hilmo

111

612

1.09

0.36

2.1

2.2

2.49

1.87

ug/l

0.68

502

Malignant neoplasm of prostate, including Hilmo

112

607

1.09

0.36

2.0

2.2

2.48

1.86

ug/l

0.68

498

Contact with machinery

272

1.18

0.36

2.2

2.3

2.54

1.98

ug/l

0.40

223

Urticaria and erythema

706

1.10

0.36

2.0

2.2

2.26

2.40

ug/l

0.13

597

Malignant neoplasm of kidney, except renal pelvis

256

0.82

0.36

2.7

2.2

3.41

1.93

ug/l

0.54

213

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.64

0.35

1.6

2.2

7.08

2.12

ug/l

—

Thiazolidinediones

342

0.85

0.35

2.3

2.2

3.28

2.13

ug/l

0.35

283

Unspecified chronic bronchitis

0.63

0.35

2.2

2.58

2.00

ug/l

—

Toxic effect of contact with venomous animals

0.63

0.35

3.2

2.3

1.98

2.11

ug/l

—

Haemorrhage in early pregnancy

337

1.15

0.35

2.4

2.3

3.28

2.83

ug/l

0.32

289

Generalized anxiety disorder

180

1.22

0.35

2.0

2.2

1.52

2.62

ug/l

1.11

157

Hyperparathyroidism

496

0.88

0.35

2.0

2.2

2.16

2.57

ug/l

0.41

424

Complications of labour and delivery

109

658

0.92

0.35

2.2

2.3

3.73

2.69

ug/l

0.61

552

Primary_lymphoid and hematopoietic malignant neoplasms

746

1.10

0.35

2.1

2.51

2.26

ug/l

0.25

614

Endometriosis of ovary

248

1.18

0.35

2.3

2.42

2.67

ug/l

0.17

214

Allergic asthma (mode)

354

0.85

0.35

2.6

2.2

1.38

2.74

ug/l

4.04

303

Superficial injury of shoulder and upper arm

236

1.19

0.34

2.3

2.92

2.41

ug/l

0.27

201

Parkinson's disease, strict definition

437

0.87

0.34

2.1

2.2

2.19

2.10

ug/l

0.06

361

Other disorders of fluid, electrolyte and acid-base balance

994

0.92

0.34

2.2

2.1

2.18

2.40

ug/l

0.23

827

Malignant neoplasm of other and unspecified female genital organs

1.37

0.34

2.0

2.4

4.15

2.38

ug/l

—

Alzheimer disease, excluding more controls

383

1.12

0.34

2.0

2.2

1.39

2.17

ug/l

4.65

332

Psoriasis vulgaris

433

1.13

0.34

2.3

2.2

1.77

2.34

ug/l

1.26

360

Non-small cell lung cancer

347

0.85

0.34

1.8

2.1

2.11

1.89

ug/l

0.21

285

Intestinal infectious diseases

263

1857

1.05

0.34

2.2

2.27

2.34

ug/l

0.13

219

1552

Depression

232

1636

0.95

0.34

2.2

2.39

2.35

ug/l

0.04

187

1371

Female genital prolapse

308

1.12

0.34

2.2

2.3

2.35

2.64

ug/l

0.27

266

Salpingitis and oophoritis

330

1.15

0.34

2.3

3.11

2.89

ug/l

0.08

290

Bursitis of shoulder

1.34

0.33

3.3

2.6

3.43

2.21

ug/l

—

Pleural plaque with presence of asbestos

237

1.18

0.33

2.4

2.2

1.58

2.12

ug/l

0.95

196

Chronic laryngitis and laryngotracheitis

349

1.15

0.33

2.4

2.2

1.69

2.62

ug/l

1.66

301

Use of antiglaucoma preparations and miotics

200

1.20

0.33

2.4

2.2

2.11

1.81

ug/l

0.42

169

Poisoning by drugs, medicaments and biological substances

349

1.15

0.33

2.5

2.2

2.08

2.69

ug/l

0.63

295

Superficial injury of abdomen, lower back and pelvis

312

1.15

0.33

2.3

2.2

2.21

2.30

ug/l

0.07

259

Generalized epilepsy

1.31

0.33

2.7

2.3

11.95

1.97

ug/l

—

Benign neoplasm: Skin of ear and external auricular canal

0.70

0.33

2.7

2.2

2.62

2.05

ug/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.68

0.33

2.2

2.3

1.00

1.89

ug/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

174

1637

1.06

0.33

2.2

2.50

2.28

ug/l

0.19

149

1356

Calculus of kidney and ureter

884

1.09

0.32

2.2

2.1

2.80

2.22

ug/l

0.49

729

Acute appendicitis

156

1541

0.94

0.32

2.3

2.2

2.32

2.24

ug/l

0.12

132

1287

Gastric ulcer

530

1.11

0.32

2.2

2.1

2.20

2.39

ug/l

0.24

435

Diseases of arteries, arterioles and capillaries

234

1628

1.05

0.32

2.1

2.2

2.64

2.24

ug/l

0.45

183

1370

Vestibular neuronitis

201

1.20

0.32

2.3

2.2

2.14

2.38

ug/l

0.17

170

Allergic rhinitis

418

0.87

0.32

2.1

2.2

1.80

2.62

ug/l

1.53

357

Focal epilepsy, strict definition

476

0.88

0.32

2.1

2.2

2.03

2.29

ug/l

0.29

396

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

313

1.15

0.32

2.3

2.2

1.99

2.35

ug/l

0.37

260

Deep bite

136

1.23

0.32

2.5

2.2

3.58

2.47

ug/l

0.29

120

Focal epilepsy

507

0.89

0.31

2.2

3.75

2.27

ug/l

0.38

422

Mood [affective] disorders

259

1740

0.95

0.31

2.2

2.44

2.35

ug/l

0.09

207

1462

Noninflammatory disorders of female genital tract

308

1.11

0.31

2.2

2.3

2.62

2.64

ug/l

0.02

266

Use of levodopa decarboxylase inhibitor

433

0.88

0.31

2.3

2.2

1.76

2.18

ug/l

0.55

355

Benign mammary dysplasia

316

0.85

0.31

1.9

2.2

1.83

2.95

ug/l

1.32

278

L02BB Anti-androgens

294

0.85

0.31

2.4

2.1

1.78

2.05

ug/l

0.32

237

Carbimazole or st.post thyroidectomy, condition for graves disease

437

1.12

0.31

2.6

2.2

2.11

2.67

ug/l

0.75

376

Endometriosis diagnosis and infertility diagnosis occurring together

0.71

0.30

2.3

2.2

2.03

3.17

ug/l

—

Alcohol use disorder, ICD-based

1048

0.93

0.30

2.3

2.2

2.06

2.21

ug/l

0.25

866

Corneal ulcer

371

1.13

0.30

2.5

2.2

3.88

2.30

ug/l

0.37

312

Other medical care

158

1247

1.06

0.30

1.8

2.2

2.16

2.29

ug/l

0.27

126

1052

Urolithiasis

103

955

1.08

0.30

2.2

2.1

2.91

2.15

ug/l

0.70

792

Otitis externa, unspecified

221

1.18

0.30

1.8

2.2

2.12

2.45

ug/l

0.20

189

Hypertrophy of breast in women and men

324

1.14

0.30

2.2

2.3

2.03

2.86

ug/l

1.27

284

Helminthiases, including avohilmo

1.30

0.30

2.6

2.2

2.13

2.31

ug/l

—

Noninfective enteritis and colitis

115

1070

1.07

0.30

2.3

2.2

2.01

2.39

ug/l

0.87

881

Injury of eye and orbit

268

1.16

0.30

2.6

2.3

2.35

2.37

ug/l

0.01

233

Conductive hearing loss, unspecified

166

1.21

0.29

2.3

2.2

2.25

2.26

ug/l

0.01

139

Purpura and other haemorrhagic conditions

306

1.14

0.29

2.1

2.2

1.93

2.14

ug/l

0.24

258

Presbyopia

157

1.21

0.29

1.6

2.2

1.52

2.79

ug/l

1.49

136

Foreign body entering into or through eye or natural orifice

152

0.79

0.29

2.3

4.33

2.01

ug/l

—

128

Volume depletion

260

0.85

0.29

2.0

2.1

1.22

1.95

ug/l

2.39

214

Infections with a predominantly sexual mode of transmission, including avohilmo

419

1.11

0.29

2.3

2.2

3.67

2.46

ug/l

0.37

353

Mood disorders

261

1744

0.96

0.28

2.2

2.44

2.35

ug/l

0.09

208

1467

Any event in cancer register

239

1330

1.05

0.28

2.4

2.3

2.19

2.32

ug/l

0.26

202

1114

Early onset COPD, excluding more controls

586

0.90

0.28

2.2

3.37

2.51

ug/l

0.27

484

Other problems related to primary support group, including family circumstances

100

1.26

0.28

2.8

2.1

2.42

3.09

ug/l

0.27

Seborrhoeic dermatitis

242

1.16

0.28

2.4

2.3

2.88

2.07

ug/l

0.28

207

Mental and behavioural disorders due to alcohol

125

1267

0.94

0.27

2.3

2.2

2.03

2.19

ug/l

0.36

103

1056

Car occupant injured in other and unspecified transport accidents

308

1.14

0.27

2.3

2.2

2.06

2.32

ug/l

0.24

261

Diaphragmatic hernia

117

1096

1.07

0.27

2.3

2.2

2.77

2.43

ug/l

0.47

898

Nonsuppurative otitis media

261

0.86

0.27

2.5

2.2

1.89

2.46

ug/l

0.51

219

Chronic diseases of tonsils and adenoids

173

1150

0.95

0.27

2.3

2.2

2.09

2.52

ug/l

1.21

138

971

Malignant neoplasm of colon

511

0.90

0.27

2.1

2.11

2.20

ug/l

0.09

424

Hypo-osmolality and hyponatraemia

552

1.10

0.27

2.3

2.1

1.75

2.46

ug/l

1.37

460

Liquid cancers

106

937

1.07

0.27

2.0

2.2

2.53

2.32

ug/l

0.26

781

Labour and delivery complicated by fetal stress [distress]

0.66

0.26

2.4

2.2

2.16

3.95

ug/l

—

Sleep disorders

226

1627

0.96

0.26

2.2

2.49

2.39

ug/l

0.16

194

1354

Ischaemic Stroke, excluding all haemorrhages

206

1445

1.05

0.26

2.2

2.14

2.29

ug/l

0.35

171

1202

Other mental disorders due to brain damage and dysfunction and to physical disease

338

1.13

0.26

2.5

2.2

1.44

2.22

ug/l

2.70

285

Cholecystitis

376

1.12

0.26

1.8

2.2

2.79

2.16

ug/l

0.24

313

All dysplastic lesions of the vulva

0.69

0.26

2.6

2.2

1.26

2.65

ug/l

—

Diabetic retinopathy

519

1.08

0.25

2.2

2.49

2.07

ug/l

0.30

422

Disorders of parathyroid gland

564

0.91

0.25

2.0

2.2

2.08

2.57

ug/l

0.62

480

Conjunctivitis (acute, non atopic), including avohilmo

277

1738

0.96

0.25

2.2

2.30

ug/l

0.01

233

1449

Benign neoplasm: salivary glands, exclude unknown (D119)

213

0.84

0.25

1.7

2.3

1.54

2.34

ug/l

1.05

183

Chronic pancreatitis

319

0.88

0.25

2.2

1.40

2.20

ug/l

2.09

260

Disorders of vitreous body

171

1548

1.05

0.24

2.3

2.2

2.43

2.41

ug/l

0.02

146

1288

Acute pancreatitis

512

1.09

0.24

2.4

2.2

2.08

2.49

ug/l

0.65

417

Lichen ruber planus, wide definition including periferal and oral lichen planus

589

1.09

0.24

2.3

2.53

ug/l

0.00

497

Selective serotonin reuptake inhibitors

285

1425

1.04

0.24

2.1

2.2

2.39

2.31

ug/l

0.10

239

1201

Open wound of wrist and hand

109

990

1.06

0.24

2.2

2.23

2.21

ug/l

0.02

813

Benign neoplasm: Skin, unspecified

1.28

0.24

2.7

2.3

2.08

1.95

ug/l

—

Hemiplegia

0.72

0.24

1.8

2.2

2.10

1.91

ug/l

—

Diabetes, insulin treatment (Kela reimbursement)

296

1697

1.04

0.23

2.1

2.2

2.04

2.40

ug/l

0.92

232

1437

Alzheimer disease, including avohilmo

133

972

0.95

0.23

2.0

2.1

1.73

2.35

ug/l

2.73

110

804

Puerperal sepsis

233

0.86

0.23

2.2

2.3

1.55

3.19

ug/l

2.48

202

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

152

1.19

0.23

2.2

2.02

3.23

ug/l

0.76

130

COPD/asthma related infections

291

1404

1.04

0.23

2.2

2.3

2.50

2.36

ug/l

0.18

243

1181

COPD/asthma/ILD related infections

291

1404

1.04

0.23

2.2

2.3

2.50

2.36

ug/l

0.18

243

1181

Iridocyclitis in diseases classified elsewhere

1.32

0.23

2.6

2.2

1.88

2.13

ug/l

—

Chronic lower respiratory diseases

334

1699

1.03

0.23

2.2

2.13

2.34

ug/l

0.37

279

1415

Primary open-angle glaucoma, strict

860

1.07

0.23

2.2

2.1

2.48

2.30

ug/l

0.18

721

Other diseases of the respiratory system

609

0.92

0.23

1.9

2.1

1.74

2.21

ug/l

1.06

499

Other respiratory disorders and diseases

609

0.92

0.23

1.9

2.1

1.74

2.21

ug/l

1.06

499

Diseases of liver

929

0.94

0.23

2.3

2.2

2.53

2.32

ug/l

0.09

767

Myocardial infarction

156

1144

0.95

0.23

2.2

2.76

2.28

ug/l

0.41

128

957

Implicit bacterial Sepsis

153

1249

1.05

0.22

2.0

2.2

2.19

2.34

ug/l

0.19

119

1049

Other or ill-defined heart diseases

0.75

0.22

2.1

1.89

2.08

ug/l

—

Twin gestation

1.25

0.22

2.6

2.1

2.18

2.57

ug/l

—

Other anxiety disorders

623

0.93

0.22

2.1

2.3

1.94

2.35

ug/l

0.88

534

Other disorders of the genitourinary system

337

0.89

0.22

2.2

1.78

2.74

ug/l

1.39

287

Ectopic pregnancy

242

0.87

0.22

2.4

2.2

2.74

2.73

ug/l

0.01

206

Corneal degeneration

1.22

0.22

2.4

2.3

1.36

2.51

ug/l

—

Suppurative and unspecified otitis media

446

0.91

0.22

2.4

2.3

2.68

2.43

ug/l

0.15

377

Urticaria

535

1.08

0.22

2.1

2.3

2.05

2.52

ug/l

0.53

452

Behavioural syndromes associated with physiological disturbances and physical factors

237

1664

0.96

0.22

2.2

2.46

2.38

ug/l

0.14

201

1385

Liquid cancers, including Hilmo

125

1045

1.05

0.21

2.0

2.2

2.45

2.38

ug/l

0.09

107

868

Erectile dysfunction, exclusion

0.00

0.21

0.0

2.0

—

1.99

—

Infection due to other mycobacteria, including avohilmo

1.19

0.21

2.0

2.2

1.90

1.91

ug/l

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.21

0.0

2.1

—

1.93

—

Appendicitis, broad definition

173

1620

0.96

0.21

2.3

2.2

2.31

2.26

ug/l

0.08

144

1357

Malignant neoplasm of cervix uteri, including Hilmo

1.19

0.21

2.2

2.4

1.46

2.17

ug/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

2.0

—

2.10

—

Other mosquito-borne viral fevers, including avohilmo

0.00

0.21

0.0

2.1

—

2.07

—

Phakomatoses, not elsewhere classified

0.00

0.21

0.0

2.4

—

2.20

—

Coronary artery bypass grafting

664

0.94

0.21

2.1

2.2

2.27

1.99

ug/l

0.21

543

Malignant neoplasm of urinary organs, including Hilmo

367

0.90

0.21

2.2

2.1

2.54

2.13

ug/l

0.20

298

Abnormal findings on diagnostic imaging of lung

173

1569

1.04

0.21

2.1

2.2

2.43

2.26

ug/l

0.14

138

1313

Malignant neoplasm of mesothelium and soft tissue

102

0.78

0.21

1.8

2.3

3.25

1.92

ug/l

—

Covid-19 suspected case

346

0.90

0.21

2.0

2.2

2.63

2.49

ug/l

0.10

293

Personality disorders, excluding more controls

343

1.11

0.21

2.2

2.3

3.95

2.43

ug/l

0.30

293

Drug-induced osteoporosis with pathological fracture

1.16

0.21

2.6

2.2

2.62

2.19

ug/l

—

Multiple gestation

1.16

0.21

2.6

2.0

2.18

2.46

ug/l

—

Benign neoplasm: Testis

0.00

0.21

0.0

2.0

—

1.90

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

2.1

—

1.72

—

Cicatricial alopecia [scarring hair loss]

0.00

0.21

0.0

2.7

—

1.70

—

Non-ischemic cardiomyopathy

119

895

1.05

0.21

2.2

2.19

2.27

ug/l

0.10

748

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

305

0.89

0.20

2.4

2.2

2.41

2.43

ug/l

0.01

254

Malignant neoplasm of urinary organs

293

0.89

0.20

2.4

2.1

2.97

1.91

ug/l

0.49

241

Other extrapyramidal and movement disorders in other diseases

692

1.07

0.20

2.2

2.11

2.51

ug/l

0.62

577

Diseases of appendix

175

1630

0.96

0.20

2.3

2.2

2.35

2.26

ug/l

0.15

146

1363

Other diseases of biliary tract

211

1.14

0.20

1.7

2.3

1.74

2.18

ug/l

0.56

171

Pedal cyclist injured in transport accident

441

1.09

0.20

2.8

2.2

2.95

2.42

ug/l

0.18

369

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

267

1530

1.03

0.20

2.2

2.07

2.40

ug/l

0.73

211

1295

Acute appendicitis, no complications

110

1152

0.95

0.20

2.3

2.2

2.47

2.31

ug/l

0.20

961

Benign neoplasm of other and ill-defined parts of digestive system

499

1.08

0.20

2.1

2.2

2.27

2.52

ug/l

0.24

416

Allergic asthma (mode), excluding more controls

336

0.90

0.20

2.6

2.2

1.38

2.77

ug/l

4.05

293

Unstable angina pectoris

132

988

1.05

0.20

2.1

2.2

2.73

2.17

ug/l

0.70

108

820

Hodgkin lymphoma, hilmo

1.20

0.19

2.3

2.73

2.12

ug/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

110

1044

1.05

0.19

2.1

2.2

2.75

2.31

ug/l

0.26

859

Other and unspecified myopathies

212

1.13

0.19

2.0

2.2

2.15

1.97

ug/l

0.18

177

Unspecific neurodegenerative disorder

174

1143

1.04

0.19

2.0

2.2

1.84

2.32

ug/l

1.79

146

944

Pregnancy examination and test

1.16

0.19

2.2

2.3

2.48

1.61

ug/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

110

1147

0.95

0.19

2.3

2.2

2.16

2.18

ug/l

0.03

949

Optic neuritis

1.18

0.19

3.5

2.3

4.47

2.64

ug/l

—

154

1397

0.96

0.19

2.3

2.2

2.11

2.21

ug/l

0.21

128

1160

Benign neoplasm: Sigmoid colon

582

0.93

0.19

2.1

2.2

2.74

2.29

ug/l

0.23

479

Anomalies of dental arch relationship, including avohilmo

252

1.11

0.19

2.4

2.2

4.60

2.56

ug/l

0.48

213

Substance abuse, excluding more controls

152

1216

1.04

0.19

2.2

2.11

2.19

ug/l

0.16

122

1015

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.15

0.19

2.2

2.3

1.28

2.32

ug/l

—

Zoster [herpes zoster]

530

0.92

0.19

2.3

2.2

2.90

2.36

ug/l

0.38

443

Vitreous haemorrhage

249

0.88

0.19

2.1

2.2

1.77

2.13

ug/l

0.28

206

Insomnia

220

1584

0.97

0.19

2.2

2.45

2.42

ug/l

0.05

188

1314

Normotensive glaucoma

251

1.12

0.18

2.4

2.2

2.08

2.20

ug/l

0.14

210

Other and unspecified disorders of vitreous body

143

1339

1.04

0.18

2.3

2.2

2.58

2.47

ug/l

0.13

124

1111

Graves disease, strict definition

156

1.15

0.18

2.1

2.2

1.71

2.73

ug/l

1.01

136

Perforation of tympanic membrane

213

1.13

0.18

2.2

1.99

2.27

ug/l

0.28

183

Other viral diseases, not elsewhere classified

298

1.10

0.18

2.4

2.2

2.16

2.30

ug/l

0.10

251

Other congenital malformations of the digestive system

1.22

0.18

2.0

2.2

1.86

2.21

ug/l

—

Enterocolitis due to Clostridium difficile

261

1.11

0.18

2.2

2.36

2.01

ug/l

0.30

223

Acute sinusitis

115

996

1.05

0.18

2.3

2.2

2.58

2.36

ug/l

0.31

827

Other conjunctival vascular disorders and cysts

1.21

0.18

1.9

2.3

1.99

2.08

ug/l

—

Unspecified abortion

1.21

0.18

2.1

2.0

1.13

1.86

ug/l

—

Pregnancy hypertension

509

1.07

0.18

2.4

2.3

3.10

2.76

ug/l

0.22

431

Other and unspecified epidermal thickening

1.19

0.18

3.3

2.3

3.16

2.23

ug/l

—

Injury of nerves at wrist and hand level

1.19

0.18

2.4

2.3

1.87

2.10

ug/l

—

Combinations of oral blood glucose lowering drugs

949

0.95

0.18

2.2

2.41

2.34

ug/l

0.04

794

Disorders of adult personality and behaviour

383

0.91

0.17

2.1

2.2

4.04

2.48

ug/l

0.29

324

Colectomy operation

476

0.92

0.17

2.0

2.2

1.71

2.23

ug/l

1.09

400

Other and unspecified urticaria

358

1.09

0.17

2.0

2.2

1.71

2.56

ug/l

1.34

303

Heartburn

262

1.11

0.17

2.4

2.2

2.13

2.20

ug/l

0.05

220

Recurrent aphthous stomatitis , including avohilmo

320

0.91

0.17

1.9

2.3

1.63

2.43

ug/l

1.25

271

LSIL lesion of the cervix uteri

110

1.18

0.17

2.8

2.2

2.76

3.09

ug/l

0.14

Contact with nonpowered hand tool

1.22

0.17

2.4

1.76

2.14

ug/l

—

Convergent concomitant strabismus

0.75

0.17

2.8

2.3

2.40

2.53

ug/l

—

Amputation of thigh

0.72

0.17

1.4

2.2

4.10

1.84

ug/l

—

Diseases of middle ear and mastoid

107

915

0.95

0.16

2.4

2.2

2.51

2.33

ug/l

0.20

760

Acute bronchitis

108

1011

1.05

0.16

2.0

2.2

2.24

2.36

ug/l

0.19

840

Other bacterial intestinal infections, including avohilmo

582

1.07

0.16

2.2

2.81

2.46

ug/l

0.31

486

Epilepsy

719

0.94

0.16

2.1

2.2

3.12

2.35

ug/l

0.27

603

Use of memantine

104

798

1.05

0.16

1.9

2.1

2.03

2.22

ug/l

0.37

659

Use of other anti-dementia drugs

104

798

1.05

0.16

1.9

2.1

2.03

2.22

ug/l

0.37

659

Hyperlipidaemia, other/unspecified

143

1235

1.04

0.16

2.1

2.19

2.38

ug/l

0.23

113

1032

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

402

0.92

0.16

2.3

2.23

2.61

ug/l

0.35

337

Abnormal serum enzyme levels

100

1011

0.95

0.16

2.3

2.2

1.86

2.03

ug/l

0.45

833

Keratitis

827

1.05

0.16

2.2

2.99

2.38

ug/l

0.28

691

Pregnancy, childbirth and the puerperium

273

1.07

0.16

2.5

2.0

1.99

2.36

ug/l

0.61

231

Disorders of breast

101

848

1.05

0.16

2.3

2.32

2.84

ug/l

1.16

730

Adverse effects, not elsewhere classified

360

1.08

0.16

2.4

2.2

1.40

2.61

ug/l

2.94

304

Malignant melanoma of skin, including Hilmo

463

0.93

0.16

2.1

2.2

1.91

2.26

ug/l

0.51

378

Acute pancreatitis (for exclusion)

525

1.07

0.16

2.4

2.2

2.08

2.47

ug/l

0.60

431

Herpesviral [herpes simplex] infections, including avohilmo

457

1.07

0.16

2.1

2.3

2.27

2.57

ug/l

0.22

384

Dilated cardiomyopathy

328

0.91

0.15

2.1

2.2

1.74

2.12

ug/l

0.42

274

Spermatocele

197

1.12

0.15

2.1

1.84

1.90

ug/l

0.06

163

Smoking dependency

197

1.12

0.15

2.3

1.59

2.34

ug/l

1.45

168

Mental and behavioural disorders due to tobacco

197

1.12

0.15

2.3

1.59

2.34

ug/l

1.45

168

Stomatitis and related lesions

431

0.93

0.15

2.1

2.2

1.57

2.44

ug/l

1.66

365

Intracerebral haemorrhage

342

1.08

0.15

1.9

2.1

1.79

2.03

ug/l

0.35

284

Fracture at wrist and hand level

749

1.05

0.14

2.1

2.2

2.23

2.36

ug/l

0.13

620

Retinal vascular occlusion

352

1.08

0.14

1.9

2.2

1.77

2.10

ug/l

0.46

294

Focal epilepsy, mode (most common among epilepsy diagnosis)

430

0.93

0.14

2.2

3.88

2.35

ug/l

0.34

357

Hypothyroidism, strict autoimmune

200

1273

1.03

0.14

2.0

2.2

2.50

2.32

ug/l

0.15

157

1078

Special screening examination for neoplasms

150

1.13

0.14

2.4

2.2

2.48

2.63

ug/l

0.08

129

Psychotic depression

112

1.16

0.14

1.7

2.1

2.85

2.79

ug/l

0.02

Benign neoplasm of meninges

254

0.91

0.14

2.4

2.2

1.83

2.37

ug/l

0.71

216

Benign neoplasm: Parotid gland

191

0.89

0.13

1.7

2.3

1.45

2.28

ug/l

1.04

166

Inflammatory bowel disease

644

0.95

0.13

2.4

2.2

1.71

2.46

ug/l

2.09

537

Retinal vascular disorders

363

1.07

0.13

1.8

2.2

1.81

2.08

ug/l

0.37

303

Substance abuse

152

1366

1.03

0.13

2.2

2.11

2.23

ug/l

0.24

122

1138

Other menopausal disorders

283

1.06

0.13

2.3

2.88

2.65

ug/l

0.17

246

Other and/or unspecified nontoxic goitre

201

0.89

0.13

1.9

2.1

2.49

2.48

ug/l

0.01

172

Diabetes medication

287

1637

1.02

0.13

2.1

2.2

2.09

2.42

ug/l

0.82

228

1383

Vasomotor and allergic rhinitis

618

0.95

0.13

2.1

2.2

1.79

2.55

ug/l

2.26

523

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

159

0.88

0.13

2.1

2.2

2.26

2.34

ug/l

0.05

136

Delivery

433

1.05

0.13

2.4

2.2

2.59

2.57

ug/l

0.02

366

Disorders of vitreous body and globe

172

1579

1.03

0.13

2.3

2.2

2.43

2.42

ug/l

0.01

147

1315

Other viral diseases, including avohilmo

573

1.05

0.13

2.3

2.2

2.31

2.37

ug/l

0.04

476

Pleural plaque

345

1.07

0.12

2.4

2.2

1.46

2.13

ug/l

1.78

279

Sudden idiopathic hearing loss

277

1.08

0.12

2.0

2.3

1.27

2.24

ug/l

2.89

235

Benign leiomyoma with endometriosis

345

1.07

0.12

2.4

2.2

1.83

2.88

ug/l

2.18

302

Abnormal findings on diagnostic imaging of other body structures

384

1.07

0.12

2.4

2.2

2.23

2.39

ug/l

0.12

326

Non-Hodgkin lymphoma, all, including Hilmo

416

0.94

0.12

2.3

2.1

2.93

2.10

ug/l

0.56

338

Follicular lymphoma, hilmo

116

0.86

0.12

2.6

2.3

2.16

2.04

ug/l

—

Persons encountering health services in circumstances related to reproduction

100

695

0.96

0.11

2.2

2.4

3.47

2.32

ug/l

0.79

589

Hypertensive heart and/or renal disease

632

1.04

0.11

2.3

2.2

2.31

2.24

ug/l

0.05

540

Other viral diseases, not elsewhere classified, including avohilmo

403

1.06

0.11

2.3

2.2

1.96

2.44

ug/l

0.58

332

Pleural effusion

484

1.05

0.11

1.8

2.1

1.47

2.14

ug/l

2.97

398

Other and unspecified psoriasis

153

1.11

0.11

1.9

2.2

2.73

2.14

ug/l

0.36

131

LSIL lesion of the cervix uteri, vagina or vulva

153

1.11

0.11

2.9

2.2

2.62

2.91

ug/l

0.16

128

Asthma and opportunity respiratory infection

105

1.14

0.11

2.4

2.2

1.61

1.95

ug/l

0.45

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

136

1273

1.03

0.11

2.4

2.2

1.86

2.35

ug/l

1.69

102

1071

Dermatitis and eczema

315

1829

1.02

0.11

2.3

2.2

2.49

2.30

ug/l

0.25

266

1526

Benign neoplasm: Rectum

557

0.95

0.11

2.1

2.2

2.10

2.37

ug/l

0.25

461

Intestinal malabsorption

1.16

0.11

2.4

2.3

2.46

1.95

ug/l

—

Enlarged lymph nodes

367

1.06

0.11

2.0

2.2

2.22

2.41

ug/l

0.16

304

Triptan medication for migraine, min. 3 purchases

621

0.96

0.10

2.5

2.3

2.44

2.65

ug/l

0.29

524

Congenital malformations of the circulatory system

252

0.92

0.10

2.3

2.2

2.82

2.42

ug/l

0.19

215

Other diseases of blood and blood-forming organs, wide

576

0.95

0.10

2.2

2.73

2.54

ug/l

0.20

477

Organic, including symptomatic, mental disorders

194

1395

0.98

0.10

2.1

2.2

1.87

2.30

ug/l

1.56

159

1165

Ocular pain

156

0.90

0.10

2.4

2.2

1.64

2.14

ug/l

0.47

135

Other viral diseases

445

1.05

0.10

2.5

2.2

2.54

2.43

ug/l

0.06

369

Malnutrition

1.14

0.10

2.0

2.3

1.28

2.44

ug/l

—

Other abnormal products of conception

158

1.08

0.10

2.1

2.3

1.93

2.69

ug/l

0.53

140

Fracture of shoulder and upper arm

908

1.03

0.10

2.3

2.2

2.63

2.42

ug/l

0.23

768

Nasal polyp

496

1.05

0.10

2.0

2.2

1.86

2.55

ug/l

1.28

415

Superficial injury of wrist and hand

349

1.06

0.10

2.0

2.3

2.31

2.57

ug/l

0.23

291

Alcohol use disorder, Swedish definition

144

1342

0.97

0.10

2.3

2.2

2.20

2.19

ug/l

0.01

119

1114

Drug-induced cataract

1.11

0.10

2.6

2.3

1.60

2.22

ug/l

—

Ulcerative enterocolitis

1.11

0.09

2.2

2.4

1.46

1.96

ug/l

—

Other bacterial intestinal infections

457

1.05

0.09

2.1

2.2

2.83

2.51

ug/l

0.25

382

Periapical abscess

111

1143

0.97

0.09

2.1

2.2

2.41

2.31

ug/l

0.12

945

Effects of foreign body entering through natural orifice

516

1.05

0.09

2.3

2.2

2.16

2.31

ug/l

0.14

419

Retinal detachment with retinal break

369

1.06

0.09

2.1

2.2

2.61

2.18

ug/l

0.32

303

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

316

0.94

0.09

2.7

2.2

4.19

2.34

ug/l

0.46

269

Pedal cyclist injured in collision with motor vehicle

1.06

0.09

2.8

2.3

2.18

2.38

ug/l

—

Disorders of the thyroid gland

263

1674

1.02

0.09

2.2

2.80

2.23

ug/l

0.78

215

1409

Benign neoplasm: Skin of other and unspecified parts of face

252

1.07

0.09

2.1

2.3

2.41

2.27

ug/l

0.11

215

Crowding of teeth, including avohilmo

1.03

0.09

1.8

2.2

1.94

ug/l

—

Chronic periodontitis, complicated

177

1687

1.02

0.09

2.4

2.2

2.30

ug/l

0.00

140

1416

Myocardial infarction, with ST-elevation

513

0.95

0.09

2.2

2.1

2.35

2.03

ug/l

0.51

414

Alzheimer’s disease, strict definition

727

1.03

0.09

2.0

2.1

1.82

2.25

ug/l

1.06

609

Thoracic aortic aneurysm

478

1.05

0.09

2.4

2.2

1.98

1.93

ug/l

0.07

394

Diplopia

321

1.06

0.09

1.8

2.3

1.72

2.16

ug/l

0.78

270

Unspecified acute lower respiratory infection

329

0.94

0.09

2.0

2.2

2.60

2.12

ug/l

0.26

273

Thyrotoxicosis, other and/or unspecified

439

1.05

0.08

2.5

2.3

2.08

2.33

ug/l

0.29

380

Injuries to the ankle and foot

157

1370

0.98

0.08

2.4

2.2

2.44

2.28

ug/l

0.29

133

1147

Suicide or other Intentional self-harm

390

0.95

0.08

2.3

2.2

2.23

2.64

ug/l

0.38

325

Contusion of ankle

1.07

0.08

2.7

2.3

1.53

2.10

ug/l

—

Foreign body on external eye

292

1.06

0.08

2.3

2.17

2.15

ug/l

0.02

241

334

1667

1.02

0.08

2.2

2.33

2.30

ug/l

0.06

284

1386

Other and unspecified disorders of skin and subcutaneous tissue

136

1.10

0.08

2.3

2.2

0.81

2.42

ug/l

—

119

Disorders of calcium metabolism

175

1.09

0.08

1.9

2.1

2.33

2.00

ug/l

0.32

147

Bacterial intestinal infections, IBD co-morbidities

469

1.04

0.08

2.1

2.2

2.82

2.47

ug/l

0.28

397

Vascular dementia

244

1.07

0.08

2.1

2.2

2.01

1.90

ug/l

0.10

201

Heart failure and bmi 25plus

135

921

0.98

0.08

2.1

2.2

2.00

2.26

ug/l

0.56

102

751

Dialysis

1.14

0.08

2.9

2.3

4.08

2.09

ug/l

—

Lichen planus, including avohilmo

509

1.04

0.08

2.3

2.26

2.60

ug/l

0.25

433

Use of donepezil

664

1.03

0.08

1.8

2.1

1.75

2.20

ug/l

1.39

559

Colon adenocarcinoma

399

0.95

0.08

2.1

2.15

2.13

ug/l

0.01

334

1.06

0.08

2.1

2.3

1.36

2.01

ug/l

—

Procreative management

403

1.04

0.07

2.4

2.3

2.44

2.37

ug/l

0.05

339

Abdominal aortic aneurysm (AAA)

281

1.06

0.07

1.9

2.1

2.10

1.95

ug/l

0.14

236

Amputation of foot

0.84

0.07

1.5

2.3

2.35

1.76

ug/l

—

Postprocedural disorders of digestive system, not elsewhere classified

0.86

0.07

2.5

2.2

1.33

2.17

ug/l

—

Use of rasagiline

0.83

0.07

1.7

2.2

4.27

2.08

ug/l

—

Other and unspecified degenerative diseases of nervous system

0.81

0.07

2.0

2.2

1.07

2.07

ug/l

—

Alcohol-induced acute pancreatitis

0.81

0.07

2.3

2.2

3.00

2.02

ug/l

—

Mental and behavioural disorders due to psychoactive substance use

156

1400

1.02

0.07

2.3

2.2

2.09

2.21

ug/l

0.25

126

1165

Other and unspecified effects of external causes

471

1.04

0.07

2.3

2.2

1.43

2.54

ug/l

3.41

399

Persistent mood disorders

412

1.04

0.07

2.0

2.3

2.19

2.42

ug/l

0.21

350

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.85

0.07

3.4

2.3

1.50

2.08

ug/l

—

Prolapse and hernia of ovary and fallopian tube

1.07

0.07

2.4

2.3

4.78

2.46

ug/l

—

Dementia in other diseases classified elsewhere

118

1.10

0.07

1.9

2.4

1.00

2.01

ug/l

—

101

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.12

0.06

2.6

2.2

5.35

2.90

ug/l

—

Inflammatory disease of uterus

167

1.08

0.06

2.3

2.2

2.33

3.36

ug/l

0.71

139

Use of ropinirole

0.84

0.06

2.5

2.4

1.54

1.94

ug/l

—

Malignant neoplasm

221

1313

0.99

0.06

2.4

2.3

2.32

2.34

ug/l

0.03

191

1101

Blepharochalasis

878

1.03

0.06

2.1

2.2

2.39

2.35

ug/l

0.04

728

Non-follicular lymphoma

254

0.94

0.06

2.4

2.2

2.01

1.96

ug/l

0.04

212

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

607

1.03

0.06

2.4

2.3

2.97

2.75

ug/l

0.16

516

Other inflammation of eyelid, including avohilmo

889

1.02

0.06

2.3

1.86

2.35

ug/l

1.46

744

Hypokalaemia

345

0.96

0.06

2.1

2.2

2.76

2.44

ug/l

0.13

289

Solid cancers, including Hilmo

223

1316

0.99

0.05

2.3

2.22

2.34

ug/l

0.21

191

1104

Hypothyroidism, strict autoimmune, 3 medication purchases required

226

1498

1.01

0.05

2.0

2.2

2.40

2.38

ug/l

0.01

176

1258

Papulosquamous disorders

106

1039

1.02

0.05

2.3

2.2

2.69

2.34

ug/l

0.17

866

Autoimmune hepatitis, wide definition

1.11

0.05

2.3

2.4

1.53

2.05

ug/l

—

Contraceptive management

414

1.03

0.05

2.1

2.4

3.57

2.42

ug/l

0.45

354

Otitis externa

514

1.03

0.05

2.1

2.2

1.78

2.56

ug/l

1.39

433

Thyroiditis, ILD-related definition

198

1.06

0.05

1.8

2.2

2.29

2.72

ug/l

0.24

171

Mood disorders, excluding more controls

256

1521

0.99

0.05

2.2

2.47

2.37

ug/l

0.10

203

1279

Other disorders of glucose regulation and pancreatic internal secretion

161

0.93

0.05

1.6

2.4

2.24

2.12

ug/l

—

139

Use of anticholinesterases

132

1001

1.02

0.05

2.0

2.1

1.95

2.33

ug/l

1.09

111

827

N06DA Anticholinesterases

132

1001

1.02

0.05

2.0

2.1

1.95

2.33

ug/l

1.09

111

827

Nonischemic cardiomyopathy

262

0.95

0.05

2.3

2.2

1.91

1.89

ug/l

0.01

217

Malignant neoplasm

222

1314

0.99

0.04

2.4

2.3

2.32

2.34

ug/l

0.04

192

1102

Complications predominantly related to the puerperium

308

1.04

0.04

2.2

2.3

1.66

3.00

ug/l

2.64

265

Respiratory insufficiency

248

1.05

0.04

1.8

2.1

1.29

2.23

ug/l

2.87

201

Persons with potential health hazards related to communicable diseases

469

0.97

0.04

2.1

2.3

1.68

2.51

ug/l

1.93

394

Benign neoplasm of other and unspecified endocrine glands

332

0.96

0.04

1.9

2.3

1.30

2.55

ug/l

2.92

280

Fracture of forearm

140

1240

1.01

0.04

2.4

2.2

2.83

2.51

ug/l

0.43

120

1034

Dementia in Alzheimer disease

480

0.98

0.04

1.9

2.1

1.68

2.26

ug/l

0.95

402

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

377

0.97

0.04

2.3

2.23

2.35

ug/l

0.10

322

Alzheimer’s disease (Late onset)

687

1.02

0.04

2.0

2.1

1.88

2.26

ug/l

0.79

579

Recurrent or chronic depression

593

0.98

0.03

2.3

1.97

2.65

ug/l

1.45

496

All influenza (not pneumonia)

299

1.04

0.03

2.3

2.2

1.88

2.01

ug/l

0.14

240

Major coronary heart disease event excluding revascularizations

200

1306

1.01

0.03

2.1

2.2

2.87

2.30

ug/l

0.59

162

1087

Nonorganic sleeping disorders, excluding more controls

339

1.03

0.03

2.3

2.2

2.48

2.35

ug/l

0.09

286

Dislocation, sprain and strain of joints and ligaments at neck level

230

1.04

0.03

2.1

2.2

1.73

2.42

ug/l

0.77

196

Thyrotoxicosis with diffuse goitre

260

0.96

0.03

2.2

1.68

2.50

ug/l

1.24

223

Dementia, including avohilmo

186

1280

0.99

0.03

2.0

2.2

1.80

2.27

ug/l

1.92

154

1066

Malignant neoplasm, including Hilmo

224

1315

0.99

0.03

2.3

2.26

2.34

ug/l

0.14

192

1102

Any mental disorder

311

1546

1.01

0.03

2.1

2.2

2.34

2.36

ug/l

0.02

247

1302

Use of rivastigmine

497

1.02

0.03

2.2

2.1

1.97

2.19

ug/l

0.23

411

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.09

0.03

2.6

2.3

5.35

3.08

ug/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

281

0.97

0.03

2.4

2.2

2.41

2.43

ug/l

0.01

238

Adenomyosis (Endometriosis of uterus)

239

0.96

0.03

2.2

2.3

2.16

2.67

ug/l

0.62

207

Melanocytic naevi

668

1.02

0.03

2.3

2.2

2.00

2.44

ug/l

0.85

557

Benign neoplasm: Pituitary gland, craniopharyngeal duct

102

1.08

0.03

1.8

2.3

2.00

1.94

ug/l

—

Foreign body or object entering through skin

112

1.07

0.03

2.3

2.4

4.46

1.99

ug/l

0.59

Diseases of peritoneum

229

0.96

0.02

2.5

2.2

1.53

2.21

ug/l

1.25

197

Urinary track infection

106

524

1.01

0.02

2.2

2.4

2.14

3.03

ug/l

1.69

452

Familial hypercholesterolemia, with ischemic heart disease

279

0.97

0.02

1.7

2.1

1.90

2.00

ug/l

0.12

229

L01XX Other antineoplastic agents

152

1.05

0.02

1.8

2.3

2.24

2.01

ug/l

0.14

132

Cardiomyopathy (excluding other)

339

0.97

0.02

2.2

2.1

1.89

2.06

ug/l

0.17

277

Dementia

178

1207

1.01

0.02

2.0

2.2

1.86

2.31

ug/l

1.62

146

1004

Psychiatric diseases

277

1379

1.01

0.02

2.1

2.2

2.42

2.33

ug/l

0.10

230

1159

Symptoms and signs concerning food and fluid intake

271

1.03

0.02

1.9

2.2

2.46

2.20

ug/l

0.21

227

Other diseases of liver

431

1.02

0.02

2.2

1.81

2.35

ug/l

1.15

362

Hypothyreosis and Thyroxine purchase for inclusion criteria

247

1626

0.99

0.02

2.1

2.2

2.42

2.34

ug/l

0.08

199

1371

Parkinson's disease, excluding more controls

369

1.02

0.02

2.1

2.2

2.13

2.20

ug/l

0.04

322

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

279

1779

1.01

0.02

2.2

2.02

2.34

ug/l

1.26

234

1489

Ill-defined and unknown causes of mortality

278

0.97

0.02

1.7

2.1

1.39

1.85

ug/l

1.69

228

Other and unspecified tonsillitis

350

1.02

0.02

2.3

2.2

2.06

2.30

ug/l

0.30

287

Hypertensive Renal Disease

103

1.07

0.02

2.9

2.2

2.07

1.95

ug/l

0.09

Other diseases of pleura

157

1354

1.01

0.01

2.0

2.2

1.75

2.31

ug/l

2.24

125

1123

Malignant melanoma of skin

372

1.02

0.01

2.2

1.90

2.25

ug/l

0.43

308

Benign neoplasm: Ascending colon

438

0.98

0.01

2.3

2.2

2.02

2.42

ug/l

0.58

364

Spontaneous abortion

508

0.99

0.01

2.2

2.54

2.78

ug/l

0.21

437

Thyrotoxicosis

578

0.99

0.01

2.4

2.3

2.67

2.59

ug/l

0.05

492

Atrophic disorders of skin

343

1.02

0.01

2.2

2.3

4.12

2.85

ug/l

0.36

295

Personality disorders

373

1.02

0.01

2.2

3.95

2.50

ug/l

0.29

313

Other disorders of conjunctiva

403

1.02

0.01

2.2

2.26

2.39

ug/l

0.09

339

Solid cancers

223

1312

1.00

0.01

2.3

2.2

2.34

ug/l

0.00

188

1100

Ulcerative colitis

497

0.99

0.01

2.3

2.2

1.66

2.55

ug/l

2.14

420

Parkinson's disease, strict definition, excluding more controls

348

1.02

0.01

2.1

2.2

2.19

2.10

ug/l

0.06

303

All influenza

673

1.01

0.01

2.4

2.2

2.18

2.34

ug/l

0.18

559

Hypothyroidism, other/unspecified

237

1562

1.00

0.00

2.1

2.2

2.43

2.26

ug/l

0.18

191

1314

Allergic contact dermatitis

234

1.03

0.00

2.4

2.3

2.82

2.60

ug/l

0.06

204

Other ill-defined and unspecified causes of mortality

254

1.02

0.00

1.7

2.1

1.41

1.88

ug/l

1.56

207

Gastroduodenal ulcer

811

1.01

0.00

2.2

2.1

2.48

2.28

ug/l

0.23

666

Other pleural conditions

294

1.02

0.00

2.0

2.2

2.24

2.06

ug/l

0.10

248

Aortic aneurysm

810

0.99

0.00

2.2

2.1

2.01

1.93

ug/l

0.14

667

Extrapyramidal and movement disorders

119

1196

0.99

0.00

2.2

2.18

2.32

ug/l

0.20

992

Malignant neoplasm, wide definition

227

1317

1.00

0.00

2.3

2.25

2.34

ug/l

0.15

194

1104

Tonsillectomy and adenotomy

484

1.01

0.00

2.5

2.3

2.06

2.53

ug/l

0.69

405

Single spontaneous delivery

433

1.00

0.00

2.4

2.2

2.57

ug/l

0.00

366

Other diseases of oesophagus

230

1.00

0.00

2.2

1.98

2.16

ug/l

0.12

192

Benign neoplasm of mouth and pharynx

248

1.01

0.00

2.0

2.2

1.47

2.22

ug/l

1.69

212

Melanocytic naevi of other and unspecified parts of face

1.01

0.00

1.9

2.1

1.22

2.27

ug/l

—

Preparatory care for dialysis

101

0.99

0.00

3.3

2.2

4.02

1.83

ug/l

—

Hypertensive Heart Disease

600

1.00

0.00

2.1

2.36

2.22

ug/l

0.09

511

Implicit viral Sepsis

599

1.00

0.00

2.2

1.62

2.27

ug/l

1.71

497

Colon adenocarcinoma, helper endpoint

379

1.00

0.00

2.1

2.2

2.15

2.08

ug/l

0.07

322

Other acute lower respiratory infections

136

1299

1.00

0.00

2.0

2.2

2.38

2.32

ug/l

0.08

114

1071

Nonorganic sleeping disorders

352

0.99

0.00

2.3

2.2

2.48

2.61

ug/l

0.08

294

Delirium, not induced by alcohol and other psychoactive substances

336

1.01

0.00

1.7

2.2

2.66

2.21

ug/l

0.35

276

Malignant neoplasm of bladder, including Hilmo

370

1.01

0.00

1.8

2.1

1.83

1.82

ug/l

0.01

294

Nephropathy related operations

297

1.01

0.00

2.6

2.3

3.08

2.06

ug/l

0.57

247

Cardiomyopathies, Primary/intrinsic

327

1.01

0.00

2.2

2.0

1.89

2.09

ug/l

0.20

263

Dysphagia

772

1.00

0.00

2.4

2.2

2.52

2.25

ug/l

0.30

637

Conjunctivitis (acute, non atopic)

569

1.00

0.00

2.2

2.46

2.38

ug/l

0.07

480

Other symptoms and signs involving the urinary system

261

1.00

0.00

1.8

2.2

1.51

1.87

ug/l

0.53

219

Mouth breathing

990

1.00

0.00

2.3

2.2

2.19

2.31

ug/l

0.14

831

Other and unspecified vascular occlusions

277

1.01

0.00

1.8

2.2

1.88

2.01

ug/l

0.11

232

Viral Sepsis

601

1.00

0.00

2.2

2.1

1.62

2.26

ug/l

1.69

499

Other appendicitis

177

1.02

0.00

2.0

2.2

2.25

2.69

ug/l

0.30

155

Abscess of anal and rectal regions

167

1.02

0.00

2.0

2.3

1.24

2.36

ug/l

2.99

142

Specific development disorders of speech and language

1.00

0.00

2.8

2.1

3.58

1.96

ug/l

—

Contusion of other and unspecified parts of foot

1.00

0.00

2.7

2.2

1.92

2.50

ug/l

—

Allergic purpura

0.98

0.00

2.4

2.3

2.00

2.21

ug/l

—

Other nonautoimmune haemolytic anaemias

0.00

0.0

2.3

—

2.32

—

Frostbite with tissue necrosis

0.00

0.0

2.2

—

2.32

—

Abnormal findings in cerebrospinal fluid

0.00

0.0

3.4

—

3.22

—

Other specified and unspecified retinal disorders

0.96

0.00

2.6

2.2

1.77

1.81

ug/l

—

Exposure to ignition of highly flammable material

0.00

0.0

2.0

—

2.21

—

0.00

0.0

2.6

—

3.02

—

Undescended testicle

0.00

0.0

2.1

—

2.36

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

0.0

2.5

—

1.62

—

Drug-induced myopathy

0.00

-0.00

0.0

3.4

—

3.22

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

2.2

—

2.48

—

Other and unspecified vaccines and biological substances

0.00

-0.00

0.0

3.4

—

3.22

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

2.1

—

1.68

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

3.4

—

3.44

—

Disorders of speech understanding and production

1.00

-0.00

2.8

2.2

4.10

2.02

ug/l

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.6

—

1.37

—

Membranous nephropathy

0.00

-0.00

0.0

2.3

—

2.13

—

Synovial hypertrophy, not elsewhere classified

0.00

-0.00

0.0

3.1

—

2.86

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

0.00

-0.00

0.0

3.0

—

2.82

—

Gilbert syndrome

0.00

-0.00

0.0

2.2

—

2.45

—

Other congenital malformations of tongue, mouth and pharynx

0.00

-0.00

0.0

3.2

—

3.26

—

Behavioural disorders, excluding more controls

0.00

-0.00

0.0

1.9

—

1.67

—

Hypertrophy of bone

0.00

-0.00

0.0

2.6

—

1.68

—

Diastasis of muscle

0.00

-0.00

0.0

2.7

—

2.73

—

Polycythaemia vera

0.98

-0.00

1.7

2.4

3.60

1.91

ug/l

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

-0.00

0.0

2.8

—

3.12

—

Other congenital malformations of the digestive system, including avohilmo

0.93

-0.00

2.0

2.3

1.86

2.04

ug/l

—

Acute hepatitis B

0.00

-0.00

0.0

2.8

—

2.82

—

Respiratory tuberculosis, not confirmed

1.00

-0.00

2.1

2.2

3.08

1.93

ug/l

—

Severe visual impairment, binocular

0.00

-0.00

0.0

3.0

—

2.93

—

Respiratory tuberculosis, not confirmed, including avohilmo

1.00

-0.00

2.1

2.2

3.08

1.93

ug/l

—

Acute hepatitis B, including avohilmo

0.00

-0.00

0.0

2.8

—

2.82

—

Granulomatous disorders of skin and subcutaneous tissue

0.96

-0.00

2.6

2.4

1.20

2.31

ug/l

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

2.3

—

2.32

—

Labyrinthine fistula

0.00

-0.00

0.0

2.8

—

2.44

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

2.8

—

2.92

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

2.3

—

2.88

—

Urethral discharge

0.00

-0.00

0.0

2.4

—

2.66

—

Adrenomedullary hyperfunction

0.00

-0.00

0.0

1.8

—

1.04

—

Cardiomyopathy due to drugs and other external agents

0.00

-0.00

0.0

2.3

—

2.25

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

2.0

—

1.94

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

2.0

—

2.03

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

2.3

—

2.14

—

Hyperprolactinaemia, drug-induced

0.00

-0.00

0.0

3.8

—

2.44

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.8

—

1.04

—

Traumatic amputation of lower leg

0.00

-0.00

0.0

1.6

—

1.04

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

2.2

—

2.58

—

Malignant neoplasm of penis

0.00

-0.00

0.0

1.9

—

2.03

—

Exposure to uncontrolled fire, not in building or structure

0.00

-0.00

0.0

2.3

—

2.15

—

Atopic conjunctivitis

0.98

-0.00

2.5

2.3

3.38

2.27

ug/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

0.92

-0.00

2.7

2.4

2.94

1.90

ug/l

—

Conduct disorder

0.00

-0.00

0.0

2.2

—

1.72

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

0.00

-0.00

0.0

3.4

—

3.12

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

2.0

—

2.62

—

Exposure to other and unspecified forces of nature

0.00

-0.00

0.0

2.1

—

2.03

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

2.6

—

1.80

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

2.8

—

2.82

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chromium [Mass/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS